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Understanding	  metastatic	  cancer	  cells	  is	  important	  to	  increasing	  the	  cancer	  survival	  rate.	  
Microfluidic	  fabrication	  allows	  us	  to	  create	  diminutive	  environments	  to	  perform	  experiments	  
on	  individual	  cells.	  This	  project	  was	  aimed	  at	  developing	  a	  design	  for	  a	  microfluidic	  device	  that	  
has	  the	  potential	  to	  separate	  metastatic	  and	  non-­‐metastatic	  cancer	  cells	  via	  chemotaxis	  
through	  a	  hydrogel	  basement	  membrane	  mimic.	  The	  team’s	  device	  allows	  for	  the	  isolation	  and	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Chapter	  1:	  Introduction	  
	  
Since	  the	  year	  2000,	  over	  10	  million	  new	  cases	  of	  cancer	  have	  been	  diagnosed	  and	  over	  
5	  million	  people	  die	  from	  cancer	  each	  year1.	  	  The	  average	  percentage	  of	  adults	  diagnosed	  with	  
cancer	  is	  approximately	  1.5%	  of	  the	  population	  in	  North	  America	  and	  Europe,	  making	  the	  
disease	  extremely	  prevalent2.	  	  Metastasis	  of	  cancer	  refers	  to	  the	  spreading	  of	  cancer	  cells	  from	  
a	  tumor	  in	  one	  part	  of	  the	  body	  to	  locations	  all	  over	  the	  body	  through	  the	  bloodstream.	  	  Over	  
90%	  of	  all	  cancer	  morbidity	  and	  mortality	  is	  associated	  with	  metastasis,	  making	  it	  an	  ideal	  
target	  for	  treatment	  of	  the	  disease3.	  	  This	  indicates	  that	  reducing	  or	  inhibiting	  metastasis	  would	  
lead	  to	  a	  significant	  increase	  in	  survival	  rate	  and	  a	  significant	  reduction	  in	  patient	  suffering.	  	  The	  
most	  recent	  advancements	  in	  metastasis	  inhibition	  involve	  interfering	  with	  signaling	  pathways	  
in	  the	  tumor	  that	  dictate	  whether	  a	  primary	  cancer	  cell	  will	  metastasize4.	  	  While	  this	  method	  
shows	  promising	  results,	  an	  effective	  treatment	  is	  still	  out	  of	  reach	  as	  all	  models	  for	  this	  line	  of	  
study	  are	  in	  vitro	  and	  have	  not	  been	  tested	  in	  humans.	  
	   One	  factor	  involved	  in	  inhibiting	  or	  encouraging	  cell	  growth	  and	  migration	  is	  the	  matrix	  
on	  which	  the	  cells	  are	  growing.	  	  There	  is	  significant	  evidence	  suggesting	  that	  the	  stiffness	  of	  the	  
matrix	  affects	  the	  ability	  of	  cells	  to	  migrate	  and	  chemically	  communicate	  with	  each	  other5.	  	  
Additionally	  tumors	  have	  been	  found	  to	  alter	  their	  stiffness	  relative	  to	  the	  surrounding	  tissue,	  
and	  behave	  differently	  when	  this	  stiffness	  was	  artificially	  changed6,7.	  	  This	  implies	  that	  matrix	  
stiffness	  plays	  a	  large	  role	  in	  the	  development	  and	  spreading	  of	  tumors,	  and	  that	  studying	  how	  
stiffness	  affects	  metastasis	  of	  cancer	  tumors	  could	  lead	  to	  new	  therapy	  or	  treatments	  for	  
cancer	  patients.	  	  	  
	   Metastasis	  does	  not	  randomly	  occur	  in	  every	  cancer	  cell;	  only	  a	  select	  number	  of	  cells	  
with	  specific	  properties	  will	  metastasize,	  suggesting	  that	  studying	  tumors	  on	  the	  cellular	  level	  
would	  be	  beneficial8.	  	  It	  has	  also	  been	  shown	  that	  single	  cells	  do	  not	  necessarily	  represent	  the	  
properties	  of	  the	  entire	  cell	  population9.	  	  Additionally,	  most	  single	  cell	  assays	  are	  achieved	  
through	  microfluidic	  processes	  and	  allow	  for	  testing	  of	  thousands	  of	  cells	  with	  only	  minimal	  
reagent	  use	  and	  culture	  time,	  which	  is	  a	  significant	  improvement	  over	  population	  based	  
assays9.	  Currently,	  metastatic	  cells	  are	  studied	  through	  staining	  of	  a	  tissue	  biopsy10.	  	  However	  
this	  method	  does	  not	  allow	  researchers	  to	  perform	  cell	  specific	  assays	  due	  to	  the	  collection	  of	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both	  metastatic	  and	  non-­‐metastatic	  cells,	  or	  for	  the	  same	  reason	  differentiate	  gene	  expression	  
between	  the	  cell	  types.	  Consequently	  there	  is	  a	  need	  for	  a	  cheap	  and	  efficient	  method	  to	  
isolate	  metastatic	  cancer	  cells	  for	  gene	  expression	  studies	  in	  single	  cells	  and	  clonal	  expansion	  
for	  personalized	  cancer	  treatments.	  
	   Due	  to	  the	  metastatic	  nature	  of	  cancer,	  the	  migration	  of	  cancer	  cells	  throughout	  the	  
body	  is	  perhaps	  one	  of	  the	  deadliest	  parts	  of	  this	  disease.	  In	  order	  to	  test	  the	  ability	  of	  the	  cells	  
to	  navigate	  through	  various	  tissues,	  the	  team	  will	  design	  a	  microfluidic	  device	  with	  the	  function	  
of	  measuring	  the	  amount	  of	  time	  taken	  for	  cancer	  cells	  to	  cross	  a	  hydrogel	  at	  different	  degrees	  
of	  stiffness;	  individual	  cells	  will	  then	  be	  captured	  for	  single	  cell	  expansion	  and	  testing.	  These	  are	  
the	  primary	  objectives	  to	  achieve	  for	  this	  project.	  	  
The	  first	  step	  to	  completing	  the	  goal	  of	  the	  project	  is	  to	  pass	  a	  number	  of	  cells	  through	  a	  
hydrogel	  barrier.	  A	  chemotactic	  agent	  was	  used	  to	  induce	  chemotaxis	  in	  cancer	  cells	  across	  a	  
hydrogel	  barrier.	  The	  stiffness	  of	  this	  barrier	  can	  be	  changed	  between	  tests	  in	  order	  to	  test	  a	  
range	  of	  tissue	  stiffness.	  With	  time	  lapse	  imaging	  the	  team	  was	  be	  able	  to	  record	  how	  long	  it	  
takes	  for	  the	  cells	  to	  migrate	  through	  the	  hydrogel.	  This	  time	  is	  related	  to	  the	  ease	  of	  migration	  
through	  tissues	  in	  the	  body,	  therefore	  giving	  the	  user	  an	  idea	  of	  which	  areas	  of	  the	  body	  the	  
specific	  cancer	  line	  will	  migrate	  through	  easiest,	  and	  therefore	  which	  areas	  are	  most	  
susceptible	  to	  metastatic	  growth.	  	  
	   As	  single	  cells	  migrate	  through	  the	  hydrogel	  they	  will	  be	  separated	  and	  deposited	  in	  
wells	  for	  expansion	  and	  testing.	  Since	  one	  single	  cell	  can	  be	  responsible	  for	  metastatic	  growth,	  
separating	  the	  more	  metastatic	  cells	  for	  testing	  allows	  us	  to	  figure	  out	  what	  drugs	  are	  more	  
likely	  to	  combat	  these	  cells.	  	  
	   In	  order	  to	  be	  successful	  in	  this	  project	  and	  produce	  an	  effective	  device,	  the	  team	  must	  
lay	  out	  numerous	  goals,	  and	  have	  a	  strategy	  for	  reaching	  them.	  The	  first	  main	  goal	  for	  this	  
project	  was	  to	  develop	  a	  design	  for	  a	  microfluidic	  device.	  The	  team’s	  strategy	  for	  completing	  
this	  involved	  research	  as	  well	  as	  discussions	  with	  the	  client	  in	  order	  to	  revise	  the	  initial	  client	  
statement.	  What	  the	  group	  hopes	  to	  determine	  are	  the	  general	  and	  second	  layer	  objectives,	  
functions,	  and	  constraints.	  The	  general	  and	  second	  layer	  objectives	  drive	  the	  characteristics	  of	  
the	  device	  (safe,	  precise,	  durable	  etc.).	  Identifying	  the	  functions	  of	  the	  device	  allow	  the	  team	  to	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accurately	  determine	  every	  precise	  task	  the	  device	  must	  accomplish.	  Recognizing	  the	  
constraints	  of	  the	  design	  permits	  the	  team	  to	  realistically	  define	  the	  design	  space	  of	  the	  
project.	  Without	  constraints,	  the	  team	  could	  design	  impractical	  devices.	  	  
	   Once	  the	  team	  has	  fully	  defined	  the	  design	  space,	  conceptual	  and	  preliminary	  designs	  
was	  developed	  that	  achieve	  the	  functions	  in	  multiple	  ways.	  These	  alternative	  designs	  will	  then	  
be	  evaluated	  in	  order	  to	  arrive	  at	  a	  final	  design.	  The	  most	  popular	  and	  effective	  evaluation	  
method	  is	  the	  Pugh	  Concept	  Selection	  Method11.	  This	  method	  involves	  comparing	  each	  
alternative	  design	  to	  a	  baseline,	  rather	  than	  to	  each	  other.	  After	  evaluating	  the	  designs,	  the	  
team	  will	  have	  a	  final	  design	  to	  move	  forward	  with	  to	  production.	  
	   The	  second	  main	  goal	  of	  the	  project	  is	  to	  successfully	  test	  the	  device.	  To	  do	  this,	  the	  
team	  will	  examine	  its	  ability	  to	  meet	  each	  of	  the	  functions	  individually.	  Thus	  the	  device	  will	  be	  
tested	  to	  determine	  a	  success	  rate	  for	  isolating	  single	  cells,	  expanding	  single	  cells	  in	  culture,	  
fabricating	  a	  hydrogel	  barrier	  for	  migration,	  encouraging	  cell	  migration,	  and	  measuring	  cell	  
migration.	  	  
	   In	  order	  to	  determine	  the	  success	  of	  single	  cell	  capture,	  the	  capture	  area	  will	  be	  
examined	  with	  a	  microscope	  shortly	  after	  seeding.	  Capture	  areas	  will	  have	  no	  cells,	  a	  single	  cell,	  
or	  multiple	  cells.	  By	  taking	  the	  ratio	  between	  wells	  with	  single	  cells	  to	  wells	  with	  multiple	  cells,	  
a	  success	  rate	  for	  single	  cell	  capture	  can	  be	  obtained.	  A	  capture	  area	  being	  empty	  does	  not	  
necessarily	  imply	  a	  failure,	  as	  this	  could	  be	  cause	  by	  overall	  low	  cell	  number.	  	  	  
	   After	  cells	  have	  been	  seeded	  in	  the	  capture	  areas,	  the	  ability	  of	  the	  cells	  to	  proliferate	  
will	  be	  examined.	  Cells	  will	  be	  cultured	  in	  an	  incubator	  with	  medium	  for	  at	  least	  3	  days.	  
Afterwards,	  cells	  will	  be	  stained	  with	  DAPI/Propidium	  Iodide	  to	  show	  relative	  numbers	  of	  live	  
and	  dead	  cells.	  The	  size	  of	  the	  cell	  colonies	  in	  relation	  to	  time	  points	  shortly	  after	  seeding	  will	  
also	  be	  examined.	  
	   The	  device’s	  ability	  to	  create	  a	  hydrogel	  barrier	  will	  be	  evaluated	  by	  adding	  a	  
fluorescently	  labeled	  die	  to	  the	  gel	  before	  fabrication.	  The	  hydrogel	  will	  be	  flowed	  into	  the	  
barrier	  area	  and	  allowed	  to	  crosslink.	  The	  hydrogels	  ability	  to	  be	  confined	  within	  the	  barrier	  
area	  can	  easily	  be	  seen	  under	  fluorescent	  microscopy.	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   Once	  the	  device	  is	  functioning,	  the	  chemotactic	  agent’s	  ability	  to	  induce	  cell	  migration	  
through	  the	  hydrogel	  barrier	  will	  be	  examined	  by	  performing	  the	  experiment	  with	  varying	  
concentrations	  of	  chemotactic	  agent	  on	  the	  downstream	  side	  of	  the	  barrier,	  eventually	  running	  
the	  experiment	  with	  low	  levels	  of	  chemotactic	  agent.	  The	  number	  of	  cells	  successfully	  migrated	  
through	  the	  barrier	  at	  different	  levels	  of	  chemotactic	  agent	  will	  disclose	  the	  effect	  of	  the	  agent	  
on	  cell	  migration.	  If	  each	  feature	  of	  the	  microfluidic	  device	  is	  functional	  during	  the	  
experimentation,	  the	  overall	  project	  will	  be	  a	  success.	  
	   Various	  techniques	  have	  been	  developed	  in	  order	  to	  isolate	  tumor	  cells	  from	  the	  blood,	  
but	  these	  processes	  are	  difficult	  due	  to	  metastatic	  cancers	  being	  admixed	  with	  the	  blood’s	  
components.	  This	  makes	  the	  isolation	  and	  characterization	  of	  these	  target	  cells	  a	  major	  
challenge	  to	  overcome12.	  	  Another	  issue	  lies	  in	  the	  genetic	  nature	  of	  cancer.	  As	  an	  example,	  
pancreatic	  cancer	  exhibits	  approximately	  50	  mutations	  in	  its	  20,000	  genes	  which	  define	  it	  as	  a	  
cancer	  cell.	  However	  these	  50	  changes	  that	  lead	  to	  cancer	  are	  not	  consistent,	  meaning	  no	  two	  
instances	  of	  cancer	  are	  the	  same13.	  Understanding	  this	  variation	  is	  crucial	  when	  trying	  to	  assess	  
how	  quickly	  cancer	  can	  spread	  through	  the	  body.	  	  
In	  order	  to	  evaluate	  how	  varying	  stiffness	  affects	  cancer	  cell	  proliferation,	  a	  system	  that	  
mimics	  the	  stiffness	  of	  natural	  tissues	  needs	  to	  be	  developed	  that	  permits	  cancer	  cell	  
migration.	  The	  goal	  of	  this	  project	  is	  to	  design	  a	  microfluidic	  system	  that	  isolates	  and	  expands	  
single	  cancer	  cells	  from	  tumor	  biopsies	  within	  a	  three-­‐dimensional,	  stiffness-­‐gradient	  
containing,	  cell-­‐encapsulating	  hydrogel.	  The	  process	  of	  photolithography	  will	  be	  employed	  to	  
create	  the	  mold	  for	  the	  microfluidic	  system.	  Once	  the	  cancer	  cells	  isolated	  within	  the	  hydrogel	  
wells,	  a	  chemotactic	  agent	  will	  be	  utilized	  to	  encourage	  the	  cancer	  cell	  migration.	  The	  team	  will	  
record	  this	  migration	  and	  draw	  conclusions	  on	  the	  cancer’s	  metastatic	  factors	  based	  on	  the	  
stiffness	  of	  the	  gel	  it	  traveled	  through.	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Chapter	  2:	  Background	  	  	  	  
	   The	  goal	  of	  this	  project	  was	  to	  design	  and	  fabricate	  a	  microfluidic	  device	  which	  allows	  
for	  the	  isolation	  and	  expansion	  of	  metastatic	  cancer	  cells.	  	  To	  assist	  in	  the	  understanding	  of	  this	  
project,	  this	  chapter	  reviews	  topics	  such	  as	  microfluidics,	  single	  cell	  capture,	  3D	  gels	  and	  3D	  cell	  
culture,	  and	  cancer	  cell	  metastasis.	  	  	  
2.1	  Microfluidics	  
Microfluidics	  is	  defined	  as	  the	  science	  of	  liquid	  flow	  through	  channels	  of	  micrometer	  
size.	  Thus	  when	  one	  designs	  a	  microfluidic	  system,	  the	  process	  involves	  the	  fabrication	  of	  
fluidic	  channels	  and	  chambers	  with	  linear	  dimensions14.	  The	  size	  of	  microfluidic	  devices	  plays	  a	  
key	  role	  in	  their	  usefulness	  for	  studying	  biological	  systems.	  Since	  the	  fluidic	  systems	  operate	  on	  
the	  micro-­‐scale,	  scientists	  are	  able	  to	  record	  greater	  quantitative	  measurements	  and	  
manipulate	  single	  cells	  via	  precisely	  calculated	  liquid	  flow.	  An	  additional	  advantage	  of	  the	  
device’s	  size	  is	  the	  fact	  that	  they	  require	  minimal	  resources	  to	  fabricate,	  making	  the	  process	  
relatively	  inexpensive.	  The	  use	  of	  the	  experimental	  samples	  within	  the	  device	  is	  also	  minimized,	  
allowing	  for	  high-­‐throughput	  analysis	  of	  cells	  or	  molecules	  depending	  on	  the	  experimental	  
purposes14.	  The	  invention	  and	  recent	  developments	  of	  soft	  lithography	  contributed	  to	  the	  
increased	  interest	  and	  feasibility	  of	  microfluidics.	  Soft	  lithography	  refers	  to	  techniques	  that	  
create	  conformable	  photomasks	  which	  can	  be	  used	  to	  replicate	  the	  design	  for	  a	  microfluidic	  
device	  onto	  a	  soft	  elastomeric	  material,	  most	  prevalently	  polydimethylsiloxane14.	  Another	  
advantage	  of	  microfluidics	  is	  the	  ability	  to	  manipulate	  the	  cellular	  micro-­‐environment	  with	  the	  
generation	  of	  several	  types	  of	  chemical	  and	  physical	  gradients.	  This	  allows	  for	  the	  study	  of	  
biological	  processes	  such	  as	  chemotaxis	  and	  morphogenesis15.	  	  	  	  
	   A	  crucial	  facet	  of	  cellular	  microfluidics	  is	  being	  able	  to	  culture	  the	  cells	  within	  the	  
device.	  The	  manipulation	  of	  biological	  systems	  is	  dependent	  on	  understanding	  intercellular	  
molecular	  interactions	  and	  mechanisms	  present	  in	  the	  cellular	  microenvironment16,17.	  In	  order	  
to	  achieve	  control	  of	  this	  environment,	  cell	  cultivation	  can	  be	  used	  to	  mimic	  cell-­‐cell	  matrix	  




2.2	  Single	  Cell	  Capture	  
The	  study	  of	  single	  cells	  provides	  the	  opportunity	  to	  better	  understand	  the	  unique	  
properties	  of	  a	  small	  percentage	  of	  cells	  within	  a	  population.	  	  Single	  cells	  can	  exhibit	  
phenotypes	  and	  gene	  expression	  that	  are	  different	  from	  the	  majority	  of	  the	  colony.	  	  These	  
differences	  can	  also	  result	  in	  functional	  changes	  such	  as	  metastatic	  cancer	  cells	  within	  a	  
tumor19.	  	  The	  ability	  to	  isolate	  these	  specific	  cells	  allows	  assays	  to	  be	  performed	  without	  
interference	  from	  normal	  cells	  in	  the	  population.	  	  Analyzing	  cells	  on	  an	  individual	  level	  gives	  a	  
more	  accurate	  representation	  of	  cell-­‐to-­‐cell	  variations	  instead	  of	  the	  average	  behavior	  of	  all	  the	  
cells	  in	  the	  colony20.	  	  As	  a	  result	  of	  this,	  if	  single	  cells	  are	  expanded,	  they	  yield	  a	  population	  with	  
uniform	  cell	  properties	  that	  can	  be	  used	  for	  a	  variety	  of	  purposes21.	  	  	  	  	  	  	  	  	  	  	  
Another	  benefit	  to	  using	  microfluidic	  devices	  to	  isolate	  cells	  is	  the	  reduced	  cost	  of	  
materials	  both	  to	  fabricate	  the	  device	  and	  to	  run	  the	  experiment.	  	  A	  reduced	  	  amount	  of	  
reagents	  and	  media	  can	  be	  used	  to	  assay	  the	  same	  number	  of	  cells,	  increasing	  the	  efficiency	  of	  
experiments	  significantly.	  	  Additionally,	  due	  to	  their	  small	  size	  and	  relative	  ease	  of	  fabrication,	  
microfluidic	  devices	  can	  be	  mass	  produced	  and	  used	  for	  large	  parallel	  analysis	  at	  a	  lower	  cost	  
than	  traditional	  methods.	  	  	  
The	  efficiency	  of	  microfluidic	  devices	  is	  further	  improved	  by	  the	  large	  number	  of	  cells	  
that	  are	  able	  to	  be	  assayed	  at	  once	  on	  such	  a	  small	  area.	  	  In	  a	  recent	  study,	  1,518/1,700	  
chambers	  in	  a	  cell	  trapping	  device	  were	  filled	  with	  cells	  before	  undergoing	  RT-­‐qPCR	  analysis.	  	  
The	  ability	  to	  collect	  hundreds	  of	  data	  points	  in	  a	  single	  experiment	  is	  extremely	  beneficial	  to	  
researchers	  with	  a	  limited	  budget22.	  
A	  variety	  of	  methods	  have	  been	  developed	  to	  manipulate	  cells	  on	  a	  microfluidic	  
platform.	  	  Optical	  trapping	  uses	  a	  focused	  laser	  beam	  and	  a	  microscope	  lens.	  	  Particles	  become	  
trapped	  in	  the	  focal	  point	  of	  the	  beam	  or	  are	  repelled	  from	  it23.	  
Arrays	  of	  microwells	  are	  also	  used	  to	  trap	  single	  cells.	  	  Cells	  are	  flowed	  into	  the	  chamber	  
and	  allowed	  to	  sediment	  into	  the	  wells.	  	  The	  current	  standard	  for	  single	  cell	  trapping	  efficiency	  
using	  this	  method	  is	  30-­‐40%.	  	  These	  arrays	  are	  often	  fabricated	  through	  soft	  lithography	  and	  
each	  well	  contains	  enough	  room	  for	  only	  one	  cell.	  	  There	  are	  three	  main	  uses	  for	  microwell	  
arrays:	  first,	  fabrication	  of	  3D	  environment	  to	  mimic	  in	  vivo	  conditions,	  second,	  culture	  of	  small	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colonies	  for	  drug	  screening,	  and	  third,	  analysis	  of	  rare	  single	  cells	  using	  live	  microscopy.	  	  Even	  
with	  their	  low	  trapping	  efficiency,	  microwell	  arrays	  still	  provide	  high	  throughput	  experiments	  
due	  to	  the	  small	  area	  used	  by	  the	  arrays	  and	  several	  microwell	  array	  devices	  have	  already	  been	  
patented25.	  	  	  
Another	  form	  of	  cell	  manipulation	  is	  cell	  separation,	  or	  cell	  sorting.	  	  This	  method	  takes	  
advantage	  of	  the	  hydrodynamic	  properties	  of	  particles	  in	  laminar	  flow.	  	  Cells	  are	  either	  flowed	  
through	  a	  spiral	  channel	  where	  larger	  cells	  will	  move	  to	  the	  outside	  of	  the	  channel	  while	  
smaller	  cells	  remain	  in	  the	  center,	  or	  they	  are	  flowed	  through	  a	  flow	  fractionation	  system	  in	  
which	  smaller	  cells	  are	  pulled	  to	  the	  outside	  of	  the	  stream	  by	  the	  shape	  of	  the	  channels	  
disrupting	  the	  flow.	  	  This	  method	  is	  useful	  for	  separating	  rare	  cells	  from	  a	  large	  sample,	  or	  for	  
sorting	  cells	  based	  on	  size26.	  
Cell	  separation	  can	  also	  be	  achieved	  through	  crossflow	  filtration.	  	  In	  this	  technique,	  the	  
cell	  sample	  is	  flowed	  through	  one	  channel	  that	  is	  separated	  from	  another	  channel	  by	  a	  semi-­‐
permeable	  membrane.	  	  When	  a	  buffer	  is	  flowed	  through	  the	  second	  channel,	  diffusion	  of	  small	  
cells	  and	  particles	  will	  occur	  across	  the	  membrane27.	  	  
Cells	  can	  also	  be	  isolated	  in	  droplets	  for	  drug	  assays,	  or	  to	  culture	  cells	  in	  low	  volume	  
conditions	  to	  increase	  concentration	  of	  a	  molecule	  released	  by	  the	  cell.	  	  Media	  with	  cells	  is	  
flowed	  through	  a	  narrow	  channel	  that	  crosses	  another	  channel	  that	  contains	  an	  oil	  and	  
surfactant	  mixture	  being	  pulse-­‐flowed	  with	  a	  syringe	  pump.	  	  Droplets	  formed	  this	  way	  have	  a	  
33%	  single	  cell	  trapping	  efficiency,	  but	  are	  produced	  at	  100	  droplets	  per	  second28.	  	  These	  
droplets	  can	  be	  used	  to	  assay	  cells	  as	  if	  they	  were	  in	  a	  microwell	  array,	  but	  are	  unique	  in	  that	  
individual	  cell	  protein	  expression	  can	  be	  measured	  from	  the	  droplet	  fluid29.	  
The	  polar	  nature	  of	  the	  cell	  membrane	  makes	  electrical	  manipulation	  a	  viable	  option.	  	  
Electrodes	  are	  used	  to	  create	  an	  electric	  field	  to	  either	  trap	  or	  direct	  cells.	  	  Cells	  can	  be	  
electroporated,	  or	  even	  lysed	  using	  a	  strong	  enough	  field.	  	  Similarly	  two	  cells	  can	  be	  fused	  using	  
this	  method.	  	  When	  combined	  with	  imaging	  software,	  electrical	  manipulation	  can	  be	  used	  to	  
autonomously	  sort	  or	  trap	  cells	  with	  speed	  of	  light	  reactions29.	  	  Arrays	  of	  micro-­‐electrodes	  on	  a	  
surface	  can	  act	  as	  attachment	  sites	  for	  cells	  that	  can	  be	  turned	  on	  or	  off.	  	  This	  allows	  for	  better	  
control	  over	  individual	  cells	  and	  easy	  release	  of	  cells	  once	  attached30.	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2.3	  3D	  Gels	  and	  3D	  Culture	  	  
In	  recent	  years	  many	  researchers	  have	  attempted	  to	  alter	  the	  conditions	  of	  cell	  culture	  
experiments	  to	  more	  closely	  resemble	  in	  vivo	  conditions.	  The	  main	  reason	  for	  this	  change	  is	  
that	  ordinary	  cell	  culture	  dishes	  are	  made	  of	  stiff	  plastic,	  which	  does	  not	  correctly	  mimic	  tissue	  
found	  in	  the	  body.	  Also	  in	  vivo	  substrates	  provide	  physical	  and	  chemical	  cues	  to	  cells	  promoting	  
proliferation	  or	  other	  cell	  functions.	  An	  effective	  alternative	  to	  culture	  on	  a	  plastic	  dish	  is	  to	  use	  
hydrogels31.	  A	  hydrogel	  is	  a	  cross-­‐linked	  network	  of	  proteins	  or	  polymers	  that	  provide	  a	  more	  
realistic	  substrate	  for	  cell	  culture.	  Hydrogels	  have	  high	  water	  content,	  and	  allow	  for	  exchange	  
of	  oxygen,	  nutrients,	  growth	  factors,	  or	  waste	  between	  cells	  and	  culture	  medium32.	  
	   In	  addition	  to	  allowing	  for	  medium	  exchange	  and	  reduced	  stiffness,	  hydrogels	  also	  allow	  
for	  3D	  culture.	  Instead	  of	  being	  restricted	  to	  a	  2D	  surface	  as	  on	  a	  culture	  plate,	  in	  hydrogels,	  
cells	  are	  free	  to	  proliferate	  and	  migrate	  in	  3-­‐dimensional	  space,	  similar	  to	  in	  vivo.	  It	  has	  been	  
reported	  that	  studying	  cell	  behavior	  on	  a	  2D	  surface	  is	  not	  sufficient,	  and	  that	  3D	  culture	  offers	  
a	  much	  more	  realistic	  cell	  environment32.	  Similarly,	  the	  same	  cell	  type	  can	  behave	  drastically	  
different	  on	  one	  substrate	  versus	  another.	  Human	  breast	  epithelial	  cells	  were	  found	  to	  behave	  
similarly	  to	  breast	  cancer	  cells	  when	  cultured	  on	  a	  2D	  culture	  plate,	  but	  later	  returned	  to	  
normal	  behavior	  in	  a	  3D	  hydrogel	  culture	  system33.	  Additionally,	  murine	  embryonic	  stem	  cells	  
produce	  substantially	  more	  collagen	  when	  grown	  in	  3D	  conditions	  versus	  2D34.	  In	  order	  to	  
ensure	  that	  a	  culture	  system	  accurately	  represents	  the	  in	  vivo	  characteristics	  of	  a	  cell,	  it	  is	  
important	  for	  the	  cell	  culture	  substrate	  to	  closely	  mimic	  that	  found	  in	  the	  body.	  
	   The	  broad	  range	  of	  hydrogels	  can	  be	  divided	  into	  two	  groups:	  synthetic	  and	  biologic.	  
Synthetic	  hydrogels	  can	  be	  made	  of	  polymers	  such	  as	  poly(vinyl	  alcohol)35,	  poly(2-­‐hydroxy	  ethyl	  
methacrylate)36,	  poly(ethylene	  glycol)37.	  Synthetic	  hydrogels	  produce	  a	  network	  of	  cross-­‐linked	  
fibers	  providing	  a	  framework	  for	  cell	  growth,	  and	  allow	  cells	  to	  produce	  and	  lay	  down	  native	  
ECM	  materials	  to	  replace	  the	  synthetic	  hydrogel	  over	  time38.	  Synthetic	  hydrogels	  also	  offer	  
consistent	  production	  and	  reproducible	  characteristics32.	  However,	  synthetic	  hydrogels	  do	  not	  
offer	  any	  biological	  features	  to	  promote	  cell	  growth.	  They	  are	  passive	  to	  cell	  proliferation,	  
unlike	  biologic	  hydrogels,	  which	  actively	  support	  cell	  growth32.	  Biologic	  hydrogels	  are	  made	  of	  
naturally	  occurring	  polymers	  or	  proteins	  in	  the	  body,	  such	  as	  collagen39,	  fibrin40,	  or	  hyaluronic	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acid41.	  Advantages	  of	  biological	  hydrogels	  include	  active	  support	  of	  cell	  growth	  and	  an	  even	  
more	  in	  vivo-­‐like	  substrate.	  Disadvantages	  include	  variability	  between	  batches,	  risk	  of	  
contamination	  and	  degradation,	  and	  complexity;	  it	  is	  difficult	  to	  determine	  which	  biological	  
factors	  may	  be	  causing	  cell	  functions,	  and	  tuning	  of	  mechanical	  and	  biological	  factors	  is	  
difficult32.	  
	   The	  stiffness	  of	  Matrigel,	  a	  biologic	  hydrogel,	  was	  measured	  using	  atomic	  force	  
microscopy	  to	  be	  roughly	  450	  Pa42.	  This	  is	  consistent	  for	  most	  hydrogels,	  and	  is	  much	  more	  
representative	  of	  actual	  tissue	  compared	  to	  plastic	  dishes	  with	  a	  measured	  stiffness	  of	  more	  
than	  100,000	  Pa43	  and	  ranging	  to	  giga	  pascals.	  The	  stiffness	  of	  a	  hydrogel	  can	  be	  adjusted	  
simply	  by	  increasing	  or	  decreasing	  the	  amount	  of	  crosslinking	  agent.	  The	  interaction	  between	  a	  
hydrogel	  and	  its	  surroundings	  can	  also	  play	  a	  role	  in	  determining	  stiffness.	  A	  hydrogel	  bonded	  
to	  a	  glass	  slide	  will	  form	  a	  type	  of	  boundary	  layer	  at	  the	  interface	  at	  which	  the	  stiffness	  of	  the	  
hydrogel	  will	  be	  very	  close	  to	  that	  of	  the	  glass.	  At	  increasing	  distances	  away	  from	  the	  glass	  
slide,	  the	  stiffness	  of	  the	  gel	  decreases44.	  Aside	  from	  stiffness,	  the	  diffusivity	  of	  the	  hydrogel	  
can	  greatly	  affect	  cell	  viability.	  Hydrogels	  with	  high	  diffusivity	  allow	  for	  rapid	  transfer	  of	  
nutrients	  and	  oxygen	  to	  the	  cells	  from	  the	  media	  and	  CO2	  and	  waste	  to	  the	  media	  from	  the	  
cells.	  The	  diffusivity	  of	  a	  24	  kDa	  protein	  through	  a	  collagen-­‐based	  hydrogel	  was	  measured	  to	  be	  
6.8	  x	  10-­‐7	  cm/second.	  Also,	  the	  diffusivity	  was	  consistent	  throughout	  the	  hydrogel,	  generating	  a	  
constant	  gradient45.	  The	  porosity	  of	  a	  gel,	  or	  the	  amount	  of	  empty	  space	  within	  it,	  can	  have	  a	  
dramatic	  effect	  on	  the	  gels	  ability	  to	  trap	  and	  hold	  growth	  factors	  or	  even	  cells.	  Collagen	  
hydrogels	  have	  been	  shown	  to	  contain	  pores	  up	  to	  200	  microns	  in	  diameter,	  and	  thus	  large	  
cells	  would	  be	  trapped	  in	  each	  pore46.	  
	   Due	  to	  the	  fact	  that	  hydrogels	  are	  a	  much	  better	  representation	  of	  native	  tissue,	  they	  
are	  good	  models	  for	  studying	  cell	  migration.	  The	  high	  water	  content,	  stiffness,	  porosity	  and	  
geometries	  of	  hydrogels	  can	  allow	  for	  cells	  to	  move	  through	  them	  as	  they	  would	  in	  vivo.	  In	  
Figure	  2.1	  cells	  were	  suspended	  in	  an	  Agarose	  gel	  in	  the	  center	  channel.	  A	  chemotactic	  agent	  
was	  then	  added	  to	  the	  top	  channel	  and	  allowed	  to	  diffuse	  to	  the	  middle	  channel,	  and	  form	  a	  
gradient	  through	  the	  hydrogel.	  In	  response	  to	  this	  gradient,	  cells	  were	  found	  to	  migrate	  




Figure	  2.1:	  Cell	  Migration	  in	  Microfluidic	  Device	  
	   	  
Hydrogels	  have	  also	  been	  used	  as	  barriers	  for	  cell	  migration,	  as	  in	  Figure	  2.2.	  Three	  
channels	  (middle,	  far	  left	  and	  far	  right	  in	  the	  figure)	  were	  separated	  by	  a	  collagen	  hydrogel	  
barrier.	  A	  hydrogel	  barrier	  was	  created	  in	  the	  device	  by	  flowing	  un-­‐crosslinked	  hydrogel	  into	  
separate	  channels,	  ending	  in	  the	  white	  boxes	  shown.	  The	  gel	  was	  kept	  from	  flowing	  into	  the	  
cell	  channels	  by	  the	  addition	  of	  small	  posts	  (small	  white	  squares).	  Cells	  seeded	  in	  the	  middle	  
channel	  were	  made	  to	  migrate	  due	  to	  the	  presence	  of	  a	  chemotactic	  agent	  gradient	  inside	  the	  
hydrogel48.	  This	  device	  demonstrates	  a	  cell’s	  ability	  locate	  a	  chemotactic	  agent	  gradient	  within	  
a	  hydrogel,	  and	  begin	  migration	  through	  the	  same	  hydrogel	  in	  response.	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Figure	  2.2:	  Cell	  Migration	  through	  Hydrogel	  Barrier	  
	   The	  physical	  and	  biochemical	  characteristics	  of	  a	  hydrogel	  can	  also	  have	  an	  effect	  on	  cell	  
migration.	  A	  stiffness	  gradient	  was	  created	  by	  bonding	  one	  side	  of	  a	  Matrigel	  hydrogel	  to	  a	  
glass	  plate.	  As	  stated	  above,	  the	  stiffness	  would	  be	  inversely	  proportional	  to	  the	  distance	  away	  
from	  the	  glass	  slide.	  Glioblastoma	  cells	  were	  then	  seeded	  throughout	  the	  gel,	  at	  different	  
stiffness,	  and	  allowed	  to	  migrate.	  It	  was	  reported	  that	  the	  cells	  migrated	  4	  times	  faster	  through	  
stiff	  gel	  compared	  to	  softer	  gel44.	  It	  has	  also	  been	  shown	  that	  making	  biochemical	  modifications	  
can	  induce	  and	  direct	  cell	  migration	  in	  Agarose	  gel.	  Rat	  dorsal	  root	  ganglia	  cells	  were	  able	  to	  
migrate	  easily	  through	  Agarose	  gel	  channels	  modified	  with	  oligopeptides49.	  Moving	  forward,	  
the	  team	  will	  need	  to	  consider	  factors	  such	  as	  synthetic	  versus	  biologic,	  stiffness,	  diffusivity,	  
porosity,	  and	  biochemical	  markers	  in	  the	  use	  of	  a	  hydrogel	  as	  a	  barrier	  to	  cell	  migration.	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2.4	  Cancer	  Cell	  Metastasis	  	  
Cancer	  cell	  metastasis	  occurs	  when	  tumor	  cells	  begin	  to	  migrate	  from	  their	  primary	  
tumor	  site	  and	  travel	  throughout	  the	  body.	  Metastasis	  in	  a	  cancer	  cell	  is	  one	  of	  the	  defining	  
factors	  in	  determining	  the	  malignancy	  of	  a	  tumor50.	  When	  a	  cancerous	  growth	  attains	  a	  certain	  
size,	  its	  cells	  can	  migrate	  throughout	  the	  body	  causing	  even	  more	  tumors.	  Thus	  what	  was	  once	  
just	  a	  growth	  in	  one	  organ	  system	  is	  now	  a	  widespread	  complication,	  increasing	  the	  chance	  of	  
multiple	  organ	  failure.	  Certain	  areas	  of	  the	  body	  are	  more	  susceptible	  to	  metastatic	  cancer	  than	  
others	  and	  this	  is	  due	  to	  the	  ease	  of	  cell	  transport	  to	  these	  areas	  as	  well	  as	  the	  tissue	  stiffness.	  
The	  tissues	  most	  likely	  to	  be	  targets	  of	  metastasis	  are	  the	  bone,	  liver,	  brain,	  and	  lung51.	  	  	  
When	  a	  cell	  breaks	  off	  of	  a	  growth,	  it	  can	  travel	  around	  the	  body	  via	  three	  different	  
ways:	  haematogenous,	  lymphatic,	  and	  transcoelomic.	  Haematogenous	  and	  lymphatic	  travel	  
refer	  to	  a	  cancer	  cell	  using	  the	  circulatory	  or	  lymphatic	  system	  respectively	  to	  travel	  throughout	  
the	  body,	  whereas	  transcoelomic	  migration	  involves	  cells	  moving	  through	  extracellular	  matrix	  
(ECM)	  to	  a	  new	  location.	  Although	  cells	  can	  travel	  in	  this	  space,	  little	  is	  known	  about	  the	  
mechanisms	  which	  affect	  migration	  and	  it	  is	  this	  type	  of	  metastasis	  that	  is	  the	  focus	  of	  this	  
study52.	  
Transcoelomic	  migration	  as	  a	  mechanism	  allows	  for	  cells	  to	  navigate	  the	  extracellular	  
matrix.	  However,	  the	  tissues	  that	  a	  cell	  may	  migrate	  through	  all	  have	  varying	  degrees	  of	  
stiffness	  and	  this	  tissue	  stiffness	  plays	  a	  major	  part	  in	  the	  migration	  of	  those	  cells53.	  A	  cell	  may	  
be	  better	  equipped	  to	  move	  through	  one	  tissue	  as	  compared	  to	  another,	  thus	  dictating	  the	  
cell’s	  destination.	  This	  is	  a	  large	  part	  of	  why	  certain	  tissues	  are	  more	  susceptible	  to	  metastasis	  
than	  others,	  and	  it	  is	  this	  factor	  that	  the	  group	  is	  looking	  to	  test.	  	  
Cells	  move	  throughout	  the	  body	  in	  reaction	  to	  different	  stimuli.	  These	  stimuli	  may	  be	  
internal,	  a	  gene	  inducing	  contraction	  or	  expansion,	  or	  external,	  a	  chemical	  signal	  that	  the	  cell	  
can	  sense.	  The	  latter	  is	  called	  chemotaxis	  and	  refers	  to	  the	  cells	  ability	  to	  sense	  chemicals	  
within	  their	  local	  area.	  It	  is	  this	  mechanism	  that	  the	  team	  will	  be	  utilizing	  to	  induce	  migration	  




Previous	  studies	  have	  shown	  that	  cells	  can	  migrate	  through	  and	  grow	  in	  certain	  
hydrogels55.	  These	  gels	  can	  be	  made	  of	  many	  different	  materials	  but	  the	  team	  plans	  on	  using	  
collagen	  for	  this	  migration	  study.	  This	  gel	  can	  also	  be	  made	  at	  different	  degrees	  of	  stiffness,	  
allowing	  for	  a	  tunable	  stiffness.	  By	  having	  a	  tunable	  stiffness,	  the	  device	  can	  simulate	  the	  
stiffness	  of	  different	  tissues,	  thus	  creating	  a	  model	  for	  testing	  how	  certain	  cancer	  cells	  will	  
migrate	  through	  different	  tissues.	  It	  has	  been	  shown	  previously	  that	  cancer	  cells	  migrate	  
differently	  depending	  on	  the	  stiffness	  of	  the	  hydrogel	  so	  it	  is	  important	  that	  this	  mechanism	  be	  
variable	  for	  testing	  purposes56.	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Chapter	  3:	  Project	  Strategy	  
	   Here	  the	  group	  discussed	  various	  aspects	  of	  the	  project	  such	  as	  the	  initial	  client	  statement,	  
revised	  client	  statement,	  and	  primary	  and	  secondary	  objectives.	  These	  aspects	  are	  analyzed	  in	  order	  to	  
determine	  how	  they	  will	  influence	  the	  design	  process.	  
3.1	  Initial	  Client	  Statement	  
The	  team	  was	  given	  the	  following	  initial	  Client	  Statement	  in	  order	  to	  define	  project	  objectives,	  
constraints,	  and	  functions.	  	  
	  
The	  aim	  of	  this	  project	  is	  to	  develop	  an	  efficient	  device	  or	  system	  to	  isolate	  and	  expand	  
single	  cells	  from	  tissue	  biopsies.	  The	  device	  should	  be	  able	  to	  trap	  and	  expand	  single	  
cells	  in	  micron	  sized	  hydrogels	  of	  varying	  stiffness	  representing	  different	  tissues.	  Ideally,	  
the	  device	  also	  should	  allow	  placement	  and/or	  arrangement	  of	  cell	  laden	  microgels	  to	  
produce	  precise	  geometries	  that	  can	  facilitate	  organ	  engineering,	  tissue	  engineering	  
and	  the	  study	  and	  analysis	  of	  cell-­‐cell	  interactions.	  	  	  
	  
The	  needs	  of	  this	  project	  are	  
1. Use	  of	  a	  microfluidic	  or	  a	  similar	  device	  
2. Choice	  of	  biocompatible	  gel	  material(s)	  with	  the	  following	  properties	  
a. suitability	  for	  use	  in	  microfluidics	  
b. fast	  gelling	  to	  trap	  single	  cells	  in	  the	  devices	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c. allow	  precise	  placement/arrangement	  of	  cell	  laden	  microgels	  to	  produce	  geometries	  
for	  studying	  cell-­‐cell	  interactions,	  development	  of	  organoids	  or	  tissue	  engineered	  
products.	  
d. allow	  real-­‐time	  monitoring	  of	  cells.	  
 
3.2	  Revised	  Client	  Statement	  
After	  meeting	  with	  the	  team’s	  project	  advisors	  to	  clarify	  the	  initial	  client	  statement	  and	  discuss	  
the	  project	  objectives	  and	  constraints,	  the	  team	  revised	  the	  initial	  client	  statement	  as	  follows:	  	  
	  
The	  aim	  of	  this	  project	  is	  to	  develop	  an	  efficient	  device	  to	  isolate	  and	  expand	  single	  cells	  
from	  large	  cancer	  cell	  populations.	  The	  device	  should	  be	  able	  to	  create	  a	  hydrogel	  barrier	  
mimicking	  a	  basement	  membrane.	  Ideally,	  the	  device	  should	  allow	  for	  the	  testing	  of	  metastatic	  
cancer	  cells	  that	  have	  been	  isolated	  due	  to	  migration.	  
3.3	  Primary	  Objectives	  
Through	  further	  discussion	  with	  the	  client	  about	  the	  initial	  client	  statement,	  and	  in	  
order	  to	  better	  define	  the	  direction	  of	  the	  project,	  the	  team	  developed	  four	  main	  objectives	  for	  
the	  device.	  These	  are	  Reliable,	  Marketable,	  Reproducible,	  and	  Efficient.	  These	  four	  objectives	  
were	  identified	  as	  the	  most	  important	  attributes	  of	  the	  device.	  In	  order	  for	  the	  device	  to	  be	  
successful,	  it	  must	  meet	  all	  of	  these	  objectives.	  	  
	   In	  order	  for	  the	  device	  to	  be	  reliable,	  it	  must	  be	  able	  to	  withstand	  any	  forces,	  
temperatures,	  or	  pressures	  exerted	  without	  failing.	  All	  physical	  features	  of	  the	  device	  such	  as	  
channel	  walls,	  posts,	  wells,	  reservoirs,	  capture	  points,	  etc.,	  must	  be	  sturdy	  enough	  to	  run	  an	  
experiment	  without	  them	  failing.	  	  
	   To	  fulfill	  the	  second	  objective	  of	  being	  marketable,	  the	  device	  must	  be	  something	  that	  
can	  be	  translated	  to	  the	  market.	  The	  team	  hopes	  that	  the	  device	  will	  eventually	  be	  successful	  
enough	  to	  be	  valuable.	  A	  marketable	  device	  is	  one	  that	  adds	  a	  new	  technology	  to	  the	  field,	  and	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is	  therefore	  innovative.	  The	  device	  must	  also	  be	  easy	  to	  use,	  as	  a	  complicated	  protocol	  will	  
decrease	  the	  likelihood	  of	  the	  device’s	  success.	  	  
	   An	  important	  attribute	  for	  the	  device	  to	  have	  is	  to	  be	  efficient.	  The	  device	  must	  allow	  
for	  “high-­‐throughput”	  testing,	  meaning	  it	  must	  accommodate	  high	  volumes	  of	  cells	  in	  short	  
time	  periods.	  It	  must	  also	  be	  efficient	  from	  a	  cost	  of	  materials	  and	  manufacture	  standpoint.	  
Finally,	  using	  the	  device	  and	  the	  performing	  the	  experiment	  must	  be	  time	  effective.	  
	   The	  final	  objective	  of	  the	  device	  is	  reproducibility.	  The	  device	  must	  function	  the	  same	  
way	  each	  time	  it	  is	  used.	  In	  the	  case	  of	  single	  cell	  capture,	  the	  capture	  areas	  must	  capture	  one	  
and	  only	  one	  cell	  repeatedly.	  The	  device	  must	  be	  able	  to	  produce	  a	  gel	  barrier	  precisely	  and	  
accurately.	  The	  reproducibility	  of	  the	  device	  is	  important	  because	  it	  will	  give	  weight	  to	  any	  
experiments	  done	  and	  results	  gathered	  from	  the	  device.	  
	   Based	  on	  client	  feedback,	  the	  four	  objectives	  were	  evaluated	  using	  a	  Pairwise	  
Comparison	  Chart	  (PCC).	  A	  PCC	  is	  effective	  for	  identifying	  which	  objectives	  are	  more	  important	  
than	  others.	  Each	  objective	  is	  compared	  to	  each	  other	  objective;	  if	  objective	  A	  is	  more	  
important	  than	  objective	  B,	  A	  receives	  a	  score	  of	  1.	  If	  A	  and	  B	  are	  of	  equal	  importance,	  A	  
receives	  .5	  points.	  If	  B	  is	  more	  important	  than	  A,	  A	  receives	  0	  points.	  A	  PCC	  completed	  by	  the	  
team	  and	  the	  team’s	  advisor	  is	  shown	  in	  Error!	  Reference	  source	  not	  found..	  The	  total	  score	  
for	  each	  objective	  is	  in	  the	  far	  right	  column.	  
	  
	   Marketable	   Reliable	   Reproducible	   Efficient	   Total	  
Marketable	   X	   0	   0	   .5	   .5	  
Reliable	   1	   X	   0	   .5	   1.5	  
Reproducible	   1	   1	   X	   1	   3	  
Efficient	   .5	   .5	   0	   X	   1	  
Table	  3.1:	  Pairwise	  Comparison	  Chart	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According	  on	  the	  table,	  the	  team’s	  objectives	  in	  order	  of	  importance	  are:	  Reproducible,	  
Reliable,	  Efficient,	  and	  Marketable.	  Based	  on	  this	  evaluation,	  the	  most	  important	  feature	  of	  the	  
device	  must	  be	  its	  ability	  to	  perform	  the	  same	  function	  repeatedly.	  This	  is	  because	  if	  the	  device	  
were	  not	  reproducible,	  and	  results	  collected	  would	  not	  be	  viable.	  	  
3.4	  Secondary	  Objectives	  
	  
	  
Figure	  3.1:	  Ranked	  Objectives	  Tree	  
The	  secondary	  objectives	  were	  ranked	  by	  the	  client	  and	  team	  within	  the	  category	  of	  
each	  primary	  objective	  as	  seen	  in	  Figure	  3.1.	  	  “Produces	  consistent	  results”	  was	  ranked	  as	  the	  
most	  important	  secondary	  objective	  because	  if	  the	  device	  cannot	  produce	  reproducible	  data,	  it	  
will	  not	  be	  useful	  for	  any	  type	  of	  research	  which	  is	  its	  intended	  purpose.	  In	  order	  to	  produce	  
these	  reproducible	  results	  the	  device	  must	  have	  consistent	  flow	  with	  no	  leakage	  or	  unintended	  
pressure	  fluctuations.	  	  After	  these	  most	  important	  objectives	  comes	  efficiency	  specifications	  
such	  as	  high	  throughput,	  short	  time	  to	  operate,	  and	  low	  cost	  which	  all	  increase	  the	  usefulness	  
of	  the	  device	  but	  are	  not	  critical	  to	  its	  function.	  	  Lastly,	  objectives	  of	  low	  importance	  are	  listed	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such	  as	  “easy	  to	  use”	  and	  “aesthetically	  pleasing”	  which	  are	  related	  to	  marketing	  of	  the	  device	  
and	  not	  related	  to	  changing	  its	  usefulness	  or	  function.	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Chapter	  4:	  Design	  Alternatives	  
	   Presented	  here	  are	  the	  preliminary	  developments	  of	  the	  group’s	  design	  including	  needs,	  
functions,	  feasibility	  studies,	  conceptual	  and	  preliminary	  designs,	  optimization,	  modeling	  and	  
preliminary	  data.	  
4.1	  Needs	  Analysis	  
	   Through	  discussions	  between	  group	  members	  and	  advisors	  as	  well	  as	  early	  
presentations	  to	  both	  the	  group’s	  advisors	  and	  outside	  faculty,	  the	  group	  identified	  and	  
evaluated	  the	  needs	  of	  the	  project.	  Identification	  of	  needs	  is	  a	  crucial	  step	  towards	  determining	  
design	  functions	  and	  constraints.	  The	  preliminary	  needs	  of	  the	  project	  are	  as	  follows:	  
• Develop	  a	  microfluidic	  system	  to	  create	  a	  3D	  hydrogel	  barrier	  that	  mimics	  the	  basement	  
membrane	  found	  in	  vivo.	  
• The	  barrier	  must	  be	  made	  of	  a	  biocompatible	  hydrogel.	  
• The	  hydrogel	  must	  be	  easily	  incorporated	  into	  the	  microfluidic	  system	  before	  the	  gel	  
crosslinks.	  
• Gel	  should	  crosslink	  quickly	  once	  inside	  the	  device	  to	  prevent	  leakage.	  
• The	  stiffness	  of	  the	  gel	  should	  be	  controlled	  in	  order	  to	  quantify	  cell	  migration	  in	  
response	  to	  changes	  in	  ECM	  stiffness.	  
• The	  gel	  must	  maintain	  structural	  viability	  throughout	  the	  entire	  experiment.	  
• Cells	  should	  be	  kept	  viable	  within	  the	  device	  for	  the	  duration	  of	  the	  experiment.	  
• Cells	  should	  be	  isolated	  based	  on	  their	  ability	  to	  migrate	  through	  the	  hydrogel	  barrier.	  
• Once	  cells	  breach	  the	  barrier,	  they	  must	  be	  isolated	  and	  captured	  as	  single	  cells.	  
• Isolated	  cells	  should	  be	  expanded	  in	  culture	  to	  allow	  for	  identification	  of	  gene	  
expression	  and	  drug	  efficacy	  studies.	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• Allow	  for	  real	  time	  continuous	  imaging	  of	  device.	  
	   The	  above	  needs	  were	  then	  compared	  with	  the	  project	  objectives	  to	  classify	  them	  as	  
either	  specific	  needs	  the	  device	  must	  meet,	  or	  as	  ones	  that	  are	  desired	  but	  not	  necessary.	  This	  
evaluation	  in	  junction	  with	  the	  needs	  listed	  above	  reveals	  that	  the	  team’s	  design	  must	  develop	  
a	  reproducible	  3D	  hydrogel	  barrier	  mimicking	  the	  basement	  membrane,	  induce	  cell	  migration	  
through	  the	  barrier	  reliably,	  maintain	  cell	  viability	  throughout	  the	  experiment,	  and	  efficiently	  
capture	  those	  cells	  that	  breach	  the	  barrier.	  
In	  addition	  to	  identifying	  the	  most	  important	  needs,	  the	  analysis	  also	  identified	  those	  
needs	  that	  are	  not	  absolutely	  crucial	  to	  the	  success	  of	  the	  project.	  These	  non-­‐crucial	  needs	  
include:	  growth	  of	  isolated	  cells	  into	  larger	  populations,	  continuous	  imaging	  of	  the	  device	  in	  
use,	  and	  tunable	  hydrogel	  stiffness.	  The	  reason	  for	  the	  classification	  of	  the	  first	  non-­‐crucial	  
need	  is	  that	  based	  on	  the	  financial	  and	  temporal	  limitations	  of	  this	  project,	  the	  group	  identified	  
this	  need	  as	  one	  that	  would	  require	  a	  disproportionate	  level	  of	  resources	  for	  its	  completion.	  
The	  second	  non-­‐crucial	  need	  was	  identified	  as	  such	  due	  to	  the	  ability	  of	  time-­‐lapse	  
photography	  to	  capture	  any	  migration	  of	  the	  cells	  through	  the	  barrier,	  as	  they	  would	  be	  moving	  
slowly.	  The	  third	  non-­‐crucial	  need	  was	  recognized	  due	  to	  the	  fact	  that	  multiple	  devices	  could	  be	  
used	  simultaneously	  in	  order	  to	  study	  the	  effects	  of	  different	  stiffness.	  
4.2	  Design	  Functions	  and	  Constraints	  
	   Following	  identification	  of	  the	  crucial	  and	  non-­‐crucial	  needs	  of	  this	  project,	  the	  group	  
then	  developed	  the	  functions	  of	  the	  device	  to	  further	  drive	  the	  design,	  and	  constraints	  in	  order	  
to	  ensure	  all	  designs	  met	  the	  manufacturing	  and	  monetary	  limits	  of	  the	  project.	  
4.2.1	  Design	  Functions	  
	   In	  order	  for	  this	  device	  to	  successfully	  isolate	  and	  capture	  metastatic	  cancer	  cells	  there	  
are	  several	  key	  functions	  it	  must	  perform.	  Apart	  from	  the	  basic	  functions	  necessary	  for	  any	  cell	  




Hydrogel	  Barrier	  Formation	  
	   The	  most	  important	  function	  for	  the	  success	  of	  this	  device	  is	  its	  ability	  to	  fabricate	  a	  
hydrogel	  barrier	  mimicking	  a	  basement	  membrane	  found	  in	  vivo.	  Therefore,	  the	  device	  must	  be	  
capable	  of	  manipulating	  and	  controlling	  a	  liquid	  hydrogel	  into	  the	  shape	  of	  a	  3D	  barrier.	  After	  
this	  is	  accomplished,	  the	  device	  must	  maintain	  the	  liquid	  hydrogel	  in	  this	  3D	  shape	  and	  form	  
while	  the	  hydrogel	  is	  cross-­‐linked	  to	  form	  a	  solid	  barrier.	  Should	  the	  device	  succeed	  at	  this	  
function,	  a	  3D	  hydrogel	  barrier	  mimicking	  the	  basement	  membrane	  will	  be	  reproducibly	  
fabricated.	  
Cell/Chemoattractant	  Seeding	  
	   Following	  the	  hydrogel	  barrier	  formation,	  the	  device	  must	  be	  used	  to	  isolate	  metastatic	  
cells	  from	  non-­‐metastatic	  cells.	  To	  do	  this,	  the	  device	  must	  be	  capable	  of	  seeding	  large	  
numbers	  of	  cells	  in	  media	  along	  one	  side	  of	  the	  barrier	  without	  compromising	  barrier	  integrity.	  
A	  similar	  process	  must	  then	  be	  undertaken	  to	  seed	  media	  containing	  a	  chemoattractant	  on	  the	  
opposite	  side	  of	  barrier	  while	  still	  maintaining	  the	  3D	  structure	  of	  the	  basement	  membrane	  
mimic.	  After	  succeeding	  at	  this	  function,	  the	  device	  will	  be	  able	  to	  induce	  cell	  migration	  
thought	  the	  barrier.	  
Single	  Cell	  Capture	  
	   After	  cells	  successfully	  breach	  the	  hydrogel	  barrier,	  they	  must	  be	  isolated	  and	  captured	  
as	  single	  cells.	  The	  design	  for	  single	  cell	  capture	  must	  ensure	  that	  cells	  are	  in	  an	  area	  conducive	  
to	  proper	  cell	  growth,	  while	  at	  the	  same	  time	  completely	  sequestered	  from	  all	  other	  cells.	  Each	  
individual	  cell	  must	  have	  its	  own	  nutrient	  supply	  and	  3D	  space	  in	  order	  to	  proliferate.	  A	  




4.2.2	  Design	  Constraints	  
	   After	  looking	  through	  the	  revised	  client	  statement,	  the	  group	  has	  determined	  that	  there	  
are	  several	  constraints	  that	  must	  be	  taken	  into	  consideration	  during	  the	  design	  of	  the	  device.	  
These	  constraints	  are:	  
• The	  device	  must	  not	  exceed	  a	  4”	  diameter	  
• The	  microfluidic	  channels	  in	  the	  device	  must	  not	  exceed	  a	  depth	  of	  100	  μm.	  	  
• The	  total	  cost	  for	  all	  materials	  and	  processes	  must	  not	  exceed	  the	  project	  budget	  of	  
$532.	  
• The	  hydrogel	  used	  must	  solidify	  within	  the	  barrier	  area	  of	  the	  device,	  and	  not	  before,	  in	  
order	  to	  not	  block	  the	  channels.	  
• The	  device	  must	  be	  able	  to	  function	  in	  an	  incubator	  in	  order	  to	  keep	  cells	  alive	  during	  
testing.	  
• Each	  experiment	  must	  not	  exceed	  3	  days	  in	  order	  to	  ensure	  that	  the	  cells	  do	  not	  perish	  
during	  the	  test.	  
	  
	   The	  methodology	  for	  developing	  microfluidic	  devices	  involves	  using	  photolithography.	  
This	  process	  etches	  a	  design	  onto	  a	  photoresist,	  which	  is	  bound	  to	  a	  silicon	  wafer.	  The	  
laboratory	  where	  the	  devices	  will	  be	  manufactured	  can	  only	  produce	  100um	  deep	  channels	  on	  
a	  4”	  inch	  wafer.	  The	  designed	  device	  must	  fit	  within	  these	  spatial	  parameters.	  
	   The	  total	  budget	  of	  this	  project	  provided	  by	  the	  Biomedical	  Engineering	  Department	  at	  
WPI	  is	  $632.	  Before	  the	  project	  began,	  $100	  was	  taken	  from	  the	  total	  budget	  in	  order	  to	  pay	  for	  
the	  materials	  of	  the	  lab	  space	  such	  as	  media,	  FBS,	  PDMS	  etc.	  This	  leaves	  the	  group	  with	  $532	  
for	  all	  other	  materials.	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   The	  device	  will	  use	  hydrogels	  at	  varying	  degrees	  of	  stiffness	  to	  test	  migration	  speed.	  In	  
order	  to	  use	  this	  material	  efficiently,	  the	  group	  will	  need	  to	  tune	  the	  amount	  of	  time	  it	  takes	  for	  
the	  hydrogel	  to	  form	  in	  the	  device.	  This	  is	  essential	  to	  the	  function	  of	  the	  device	  because	  the	  
gel	  is	  an	  integral	  portion	  of	  testing	  and	  must	  function	  accordingly.	  
The	  device	  will	  require	  the	  passage	  and	  growth	  of	  cells	  within	  it.	  This	  means	  that	  the	  
device	  must	  be	  able	  to	  be	  placed	  in	  an	  incubator	  at	  37oC	  and	  5%	  CO2.	  In	  conjunction	  with	  this,	  
the	  testing	  of	  the	  device	  must	  not	  exceed	  the	  average	  life	  span	  of	  the	  cell	  types	  used.	  If	  it	  takes	  
too	  long	  to	  acquire	  the	  desired	  data,	  the	  cells	  could	  die	  before	  testing	  is	  complete.	  	  
4.3	  Feasibility	  Studies	  and	  Experiments	  	  	   In	  preparation	  for	  using	  hydrogel	  retention	  posts	  as	  a	  main	  design	  feature	  within	  the	  
microfluidic	  devices	  as	  well	  as	  the	  cell	  types	  that	  were	  chosen	  to	  test	  the	  design,	  certain	  studies	  
and	  experiments	  are	  needed	  to	  determine	  the	  success	  of	  the	  final	  microfluidic	  devices.	  
4.3.1	  Cross	  Section	  of	  Devices	  
In	  order	  to	  determine	  if	  the	  microfluidic	  features	  had	  fully	  developed	  on	  the	  silicon	  
wafer	  and	  thus	  were	  being	  transferred	  onto	  the	  PDMS	  devices,	  a	  feature	  verification	  study	  
designed	  by	  the	  group	  was	  conducted.	  	  Once	  the	  photolithographic	  procedure	  was	  complete	  
and	  a	  silicon	  wafer	  with	  microfluidic	  features	  was	  produced,	  the	  group	  poured	  PDMS	  over	  the	  
wafer	  to	  create	  the	  microfluidic	  devices.	  From	  there	  the	  group	  determined	  which	  design	  
features	  were	  the	  most	  significant,	  these	  being	  the	  hydrogel	  retention	  posts	  as	  well	  as	  the	  cell	  
capture	  wells.	  A	  razor	  blade	  was	  used	  to	  cut	  a	  1	  mm	  slice	  off	  each	  device	  where	  the	  features	  
were	  most	  prominent.	  The	  location	  of	  the	  slices	  that	  were	  taken	  can	  be	  seen	  in	  Figure	  4.1	  and	  
Figure	  4.2.	  The	  slices	  were	  then	  placed	  on	  a	  hemocytometer	  to	  provide	  a	  scale	  for	  the	  features	  
and	  the	  slices	  were	  images	  using	  a	  microscope.	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Figure	  4.1:	  Hydrogel	  Retention	  Posts	  Cross	  Section	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Figure	  4.2:	  Cell	  Capture	  Wells	  Cross	  Section	  	  
4.3.2	  BrdU	  Proliferation	  Assay	  	   After	  the	  group	  had	  chosen	  the	  cells	  types	  that	  would	  be	  tested	  within	  the	  microfluidic	  
devices,	  it	  was	  determined	  that	  their	  proliferative	  abilities	  needed	  to	  be	  evaluated.	  To	  knock	  
down	  the	  proliferation	  of	  the	  cell,	  the	  group	  chose	  to	  treat	  the	  cells	  with	  mitomycin-­‐C,	  a	  
compound	  used	  as	  a	  chemotherapeutic	  agent	  as	  it	  crosslinks	  the	  DNA	  of	  cells	  thus	  halting	  their	  
division.	  	  To	  monitor	  instances	  of	  cell	  proliferation,	  the	  group	  chose	  to	  perform	  a	  cell	  
proliferation	  assay	  using	  bromo-­‐deoxyuridine	  (BrdU).	  BrdU	  is	  an	  analog	  of	  thymidine,	  which	  
means	  it	  can	  replace	  it	  as	  new	  DNA	  is	  synthesized	  in	  replicating	  cells.	  Anti-­‐BrdU	  antibodies	  are	  
then	  used	  to	  detect	  the	  incorporated	  chemical	  by	  using	  immunohistochemistry	  techniques	  and	  
thus	  it	  can	  be	  determined	  if	  the	  cells	  are	  proliferating.	  Since	  mitomycin-­‐C	  was	  used	  to	  halt	  cell	  
proliferation,	  the	  group	  wished	  to	  determine	  which	  if	  the	  chosen	  cells	  were	  able	  to	  resist	  the	  
crosslinkage.	  Before	  the	  assay	  was	  performed,	  a	  6x3	  array	  of	  24-­‐well	  plate	  was	  seeded	  with	  the	  
three	  cell	  types	  the	  group	  chose.	  The	  cells	  were	  treated	  with	  a	  range	  of	  concentrations	  of	  
mitomycin-­‐C	  from	  5	  μg/mL	  to	  25	  μg/mL	  in	  increments	  of	  five	  with	  a	  control	  in	  complete	  media	  




	   NIH/3T3,	  5	  ug/mL	   NIH/3T3,	  10	  ug/mL	   NIH/3T3,	  15	  ug/mL	   NIH/3T3,	  20	  ug/mL	   NIH/3T3,	  25	  ug/mL	   NIH/3T3,	  Control	  PANC-­‐1,	  	  5	  ug/mL	   PANC-­‐1,	  	  10	  ug/mL	   PANC-­‐1,	  	  15	  ug/mL	   PANC-­‐1,	  	  20	  ug/mL	   PANC-­‐1,	  	  25	  ug/mL	   PANC-­‐1,	  	  Control	  A172,	  5	  ug/mL	   A172,	  10	  ug/mL	   A172,	  15	  ug/mL	   A172,	  20	  ug/mL	   A172,	  25	  ug/mL	   A172,	  5	  Control	  Unused	  	   Unused	   Unused	   Unused	   Unused	   Unused	  
Table	  4.1:	  Mitomycin	  Experimental	  Layout	  The	  cell	  assay	  was	  performed	  according	  to	  the	  following	  protocol	  outlined	  in	  Appendix	  C.	  	  
4.3.3	  Mitomycin	  Scratch	  Assay	  
	   Once	  the	  group	  had	  assessed	  the	  proliferative	  ability	  of	  the	  chosen	  cells,	  the	  next	  step	  
was	  to	  measure	  their	  migratory	  ability.	  To	  do	  this,	  the	  group	  employed	  a	  scratch	  assay.	  This	  
was	  done	  by	  first	  plating	  the	  three	  cell	  types	  in	  one	  row	  of	  a	  6-­‐well	  plate	  in	  complete	  media.	  
Once	  the	  cells	  had	  grown	  to	  confluency,	  they	  were	  treated	  for	  3	  hours	  with	  complete	  media	  
containing	  Mitomycin-­‐C	  at	  a	  concentration	  of	  15	  ug/mL.	  After	  the	  elapsed	  period,	  the	  media	  
was	  changed	  back	  to	  complete	  cell	  media	  and	  a	  line	  with	  a	  marker	  was	  drawn	  on	  the	  bottom	  of	  
each	  well	  as	  a	  point	  of	  reference.	  A	  P-­‐1000	  micropipette	  tip	  was	  then	  used	  to	  scratch	  away	  the	  
cells	  along	  the	  drawn	  line	  and	  leave	  empty	  space	  on	  the	  well.	  The	  cell’s	  migration	  with	  




4.4	  Conceptual	  Designs	  	  	   After	  identifying	  the	  objectives	  the	  team	  wanted	  to	  meet	  and	  functions	  that	  the	  device	  
should	  perform	  a	  conceptual	  design	  for	  both	  the	  migration	  device	  and	  the	  single	  cell	  capture	  
device.	  	  	  
	  
Figure	  4.3:	  Migration	  Device	  Conceptual	  Design	  	   The	  migration	  device	  concept	  can	  be	  seen	  in	  Figure	  4.3	  above.	  	  The	  device	  would	  isolate	  
metastatic	  cells	  by	  inducing	  their	  migration	  through	  a	  hydrogel	  barrier	  with	  a	  chemoattractant	  
on	  the	  other	  side.	  	  After	  the	  metastatic	  cells	  travel	  through	  the	  barrier	  they	  would	  be	  collected	  




Figure	  4.4	  –	  Single	  Cell	  Capture	  Device	  Conceptual	  Design	  
The	  single	  cell	  capture	  concept	  can	  be	  seen	  in	  Figure	  4.4	  above.	  	  This	  device	  would	  consist	  of	  an	  
array	  of	  microwells	  cast	  in	  PDMS.	  	  The	  isolated	  cells	  from	  the	  migration	  device	  would	  be	  seeded	  
on	  top	  of	  the	  wells	  and	  allowed	  to	  settle.	  	  Once	  the	  cells	  have	  attached,	  loose	  cells	  would	  be	  
washed	  away	  with	  PBS,	  leaving	  behind	  single	  metastatic	  cells	  in	  wells	  than	  can	  then	  be	  









4.5	  Preliminary	  and	  Alternative	  Designs	  	  
	   After	  developing	  the	  conceptual	  designs,	  the	  group	  brainstormed	  ways	  to	  transfer	  these	  
designs	  into	  actual	  devices.	  Presented	  in	  this	  section	  are	  the	  details	  of	  the	  preliminary	  designs.	  
4.5.1	  First	  Iteration	  Migration	  Device	  
In	  order	  to	  gather	  a	  better	  understanding	  of	  how	  the	  team	  would	  achieve	  cellular	  
migration	  across	  a	  hydrogel	  as	  well	  as	  single	  cell	  capture,	  the	  team	  designed	  their	  first	  
photomask	  with	  several	  varied	  parameters.	  	  
Figure	  4.5:	  Migration	  Device	  First	  Iteration	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Figure	  	  SEQ	  Figure	  \*	  ARABIC	  1	  
The	  first	  design	  of	  the	  team’s	  migration	  device,	  shown	  in	  Figure	  4.5	  has	  a	  4mm	  long	  and	  
200µm	  wide	  channel	  for	  the	  hydrogel	  to	  flow	  through	  as	  well	  as	  200µm	  by	  50	  µm	  retention	  
posts	  spaced	  100	  µm	  apart	  to	  keep	  the	  hydrogel	  in	  place.	  The	  design	  also	  featured	  six	  2	  mm	  
inlet	  and	  outlet	  ports	  for	  the	  loading	  of	  cells	  and	  chemotactic	  agents.	  The	  other	  designs	  on	  the	  
first	  wafer	  were	  similar	  to	  this	  initial	  design,	  but	  with	  various	  changes	  in	  certain	  parameters	  for	  
testing	  purposes.	  The	  different	  parameters	  the	  team	  tested	  in	  addition	  to	  the	  first	  design	  
include:	  12mm,	  7mm,	  and	  1mm	  long	  hydrogel	  channels,	  400	  µm,	  100	  µm,	  and	  50	  µm	  wide	  
hydrogel	  channels,	  200	  µm	  and	  50	  um	  spacing	  between	  retention	  posts,	  and	  100	  um	  by	  50	  µm	  
posts.	  Two	  iterations	  also	  had	  horizontal	  posts	  in	  the	  middle	  of	  the	  hydrogel	  channel	  in	  order	  to	  
allow	  for	  the	  possibility	  of	  two	  different	  hydrogels	  
being	  flowed	  in	  from	  either	  side.	  
4.5.2	  First	  Iteration	  Capture	  Device	  
The	  initial	  design	  of	  the	  single	  cell	  capture	  device	  consisted	  of	  100	  µm	  by	  100	  µm	  square	  
wells	  shown	  in	  other	  dimensions	  the	  team	  tested	  were	  50	  µm,	  25	  µm,	  and	  10	  µm	  wells.	  Each	  	  
	   Figure	  4.6:	  Capture	  Device	  First	  Iteration	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well	  was	  separated	  by	  a	  distance	  equal	  to	  its	  width.	  The	  intent	  of	  the	  wells	  was	  to	  seed	  a	  low	  
density	  solution	  of	  cells	  on	  top	  of	  the	  device,	  allow	  the	  cells	  to	  settle	  into	  the	  wells,	  and	  then	  
wash	  any	  excess	  cells	  off	  the	  top	  with	  PBS.	  
4.5.3	  Second	  Iteration	  Migration	  Device	  
After	  testing	  the	  first	  design,	  the	  team	  determined	  that	  they	  needed	  to	  revise	  both	  the	  
migration	  and	  single	  cell	  capture	  devices.	  For	  both	  of	  the	  initial	  devices,	  the	  dimensions	  
prevented	  certain	  features	  from	  developing	  during	  the	  photolithography	  process.	  




	   Our	  second	  design	  of	  the	  migration	  device	  focused	  on	  the	  1mm	  and	  4mm	  long	  hydrogel	  
barrier	  channels	  with	  a	  200	  µm	  width.	  In	  order	  to	  ensure	  that	  all	  features	  would	  develop,	  no	  
posts	  had	  dimensions	  under	  100	  µm.	  The	  primary	  device	  for	  the	  second	  design,	  seen	  in	  Figure	  
4.7,	  has	  several	  key	  differences.	  The	  most	  notable	  is	  the	  centering	  of	  the	  hydrogel	  channel	  and	  
the	  addition	  of	  an	  inlet	  and	  outlet	  channel	  on	  the	  right	  side	  of	  the	  device.	  The	  hydrogel	  
retention	  post	  sizes	  the	  team	  tested	  were	  200	  µm	  by	  100	  µm,	  100	  µm	  by	  200	  µm,	  and	  200	  by	  
200	  µm.	  	  
Along	  with	  these	  altered	  dimensions,	  two	  “fail-­‐safe”	  devices	  were	  also	  included.	  These	  
two	  devices	  were	  a	  1mm	  and	  4mm	  device	  with	  very	  small	  openings	  in	  the	  hydrogel	  barrier	  
channel	  in	  order	  to	  ensure	  that	  the	  hydrogel	  would	  form	  properly	  and	  remain	  rigid	  during	  the	  
cell	  loading	  procedure.	  The	  1mm	  “fail-­‐safe”	  device	  only	  had	  a	  200	  µm	  gap	  for	  the	  cells	  to	  pass	  
through	  while	  the	  4	  mm	  “fail-­‐safe”	  device	  had	  three	  200	  µm	  gaps.	  
4.6	  Optimization	  	   Immediate	  problems	  with	  the	  first	  design	  were	  noted	  after	  fabricating	  the	  first	  iteration	  
of	  devices.	  	  The	  design	  called	  for	  a	  barrier	  retention	  post	  width	  of	  50um.	  	  These	  features	  were	  
too	  small	  to	  be	  fully	  developed	  during	  the	  photolithography	  process,	  and	  so	  the	  posts	  were	  too	  
short	  to	  contact	  the	  glass	  slide.	  	  This	  could	  allow	  for	  fluid	  to	  leak	  underneath	  the	  posts	  and	  they	  
could	  not	  serve	  their	  function.	  	  To	  correct	  this,	  the	  second	  design	  increased	  the	  barrier	  
retention	  post	  width	  to	  200um	  to	  allow	  for	  full	  development	  of	  the	  posts.	  	  Additionally,	  to	  
further	  increase	  the	  ability	  of	  the	  development	  solution	  to	  penetrate	  the	  small	  posts,	  the	  
photoresist	  height	  was	  changed	  from	  100um	  to	  40um.	  
	   It	  was	  also	  noted	  that	  the	  inlet	  for	  the	  chemoattractant	  did	  not	  have	  an	  outlet	  to	  allow	  
for	  removal	  and	  collection	  of	  the	  metastatic	  cells	  that	  migrate	  through	  the	  barrier.	  	  An	  outlet	  
would	  also	  provide	  symmetry	  to	  the	  device	  so	  that	  either	  side	  of	  the	  barrier	  could	  be	  used	  for	  
cells	  or	  a	  chemoattractant.	  	  For	  these	  reasons,	  an	  outlet	  was	  added	  to	  the	  right	  side	  of	  the	  
device	  and	  the	  inlet	  channel	  was	  moved	  to	  make	  the	  device	  provide	  symmetrical	  flow	  along	  
either	  side	  of	  the	  barrier.	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   The	  final	  optimization	  of	  the	  first	  iteration	  of	  devices	  was	  to	  reduce	  the	  length	  of	  the	  
barrier	  from	  4mm	  to	  1mm	  on	  all	  devices.	  	  While	  theoretically	  the	  length	  of	  the	  channel	  should	  
not	  affect	  the	  barrier	  formation,	  because	  the	  4mm	  barrier	  is	  longer,	  it	  allows	  for	  more	  
opportunities	  for	  failure.	  	  Thus	  to	  increase	  the	  output	  efficiency	  of	  the	  barrier	  formation	  
process,	  the	  barrier	  length	  was	  shortened	  to	  1mm.	  
4.7	  Water	  Modeling	  	   Before	  using	  the	  devices	  with	  a	  hydrogel,	  water	  was	  used	  to	  test	  the	  ability	  of	  the	  
barrier	  retention	  posts	  to	  maintain	  a	  continuous	  barrier	  of	  fluid.	  	  The	  devices	  were	  set	  up	  with	  a	  
syringe	  containing	  water	  and	  green	  dye	  in	  the	  hydrogel	  inlet,	  and	  the	  water	  was	  allowed	  to	  
slowly	  flow	  into	  the	  device	  by	  changing	  the	  height	  of	  the	  syringe	  reservoir.	  	  Initially,	  a	  1mm	  
device	  was	  used	  as	  seen	  is	  Figure	  4.8.	  The	  water	  entered	  the	  barrier	  channel,	  and	  bubbled	  out	  
in	  all	  directions,	  but	  was	  contained	  to	  the	  barrier	  channel	  by	  the	  surface	  tension	  of	  the	  water	  
between	  the	  posts.	  	  	  
	  




Figure	  4.9	  –	  4mm	  Device	  Model	  of	  Hydrogel	  Barrier	  Using	  Water	  and	  Green	  Dye	  
 
Using	  the	  same	  procedure,	  water	  barriers	  of	  4	  mm	  were	  also	  successfully	  created,	  
shown	  in	  Figure	  4.9	  above.	  The	  surface	  tension	  of	  the	  water	  combined	  with	  the	  capillary	  action	  
of	  the	  hydrogel	  retention	  posts	  was	  able	  to	  control	  the	  advancing	  water	  through	  the	  hydrogel	  
barrier	  area	  and	  into	  the	  hydrogel	  outlet.	  Barriers	  were	  successfully	  formed	  in	  devices	  in	  which	  
the	  distance	  between	  the	  hydrogel	  retention	  posts	  was	  100	  micrometers,	  as	  above.	  	  Any	  device	  
with	  a	  retention	  post	  spacing	  of	  more	  than	  100um	  was	  unable	  to	  maintain	  a	  barrier	  as	  seen	  is	  
Figure	  4.10	  below.	  	  The	  space	  between	  the	  posts	  was	  too	  great	  to	  for	  the	  surface	  tension	  of	  the	  




Figure	  4.10	  –	  4mm	  Device	  Model	  of	  Failed	  Hydrogel	  Barrier	  
	  
4.8	  Preliminary	  Data	  	   Data	  obtained	  from	  feasibility	  studies	  and	  experiments	  are	  included	  in	  this	  section	  of	  
the	  report.	  Quantitative	  and	  qualitative	  results	  are	  included	  for	  the	  cross	  sections	  of	  the	  
microfluidic	  devices,	  cell	  proliferation	  assay	  using	  5’	  bromo-­‐deoxyuridine	  (BrdU),	  and	  the	  
mitomycin-­‐C	  scratch	  assay.	  	  
4.8.1	  Cross	  Section	  of	  Devices	  
	   The	  images	  collected	  by	  way	  of	  bright-­‐field	  microscopy	  are	  pictured	  below	  in	  Figure	  





Figure	  4.11:	  Hydrogel	  barrier	  Retention	  Posts	  Cross	  Section	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
	  
Figure	  4.12:	  Single	  Cell	  Capture	  Wells	  Cross	  Section	  
	  	  	  	  	  	  	  	  
These	  features	  were	  developed	  to	  be	  at	  a	  40	  μm	  thickness	  from	  the	  bottom	  of	  the	  
device.	  Using	  the	  hemocytometer	  array	  within	  the	  images	  of	  the	  cross	  sections	  as	  a	  reference	  
point,	  the	  group	  was	  able	  to	  determine	  that	  the	  features	  of	  the	  fabricated	  microfluidic	  devices	  
were	  fully	  developed	  and	  operable	  for	  experimentation.	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4.8.2	  BrdU	  Proliferation	  Assay	  
	  
	   The	  BrdU	  stained	  cells	  were	  imaged	  by	  way	  of	  fluorescent	  microscopy.	  Since	  the	  cells	  
were	  stained	  for	  Hoechst	  and	  BrdU,	  two	  images	  of	  each	  well	  containing	  cells	  were	  taken	  
exhibiting	  each	  fluorescence.	  The	  number	  of	  fluorescing	  cells	  from	  the	  identical	  pictures	  were	  
counted	  using	  ImageJ	  imaging	  software.	  The	  number	  of	  cells	  fluorescing	  BrdU	  were	  compared	  
to	  the	  total	  number	  of	  cells	  fluorescing	  Hoechst	  as	  a	  percentage,	  thus	  showing	  the	  number	  of	  
cells	  proliferating	  when	  treated	  with	  mitomycin-­‐C	  the	  results	  are	  shown	  in	  Figure	  4.13	  below.	  	  	  	  
	  
	  
Figure	  	  4.13:	  BrdU	  Proliferation	  Data	  
As	  expected,	  the	  control	  cell	  the	  group	  chose,	  NIH/3T3	  cells,	  was	  the	  especially	  
successful	  at	  being	  treated	  with	  mitomycin.	  Across	  all	  the	  concentration	  treatments	  the	  cells	  
remain	  relatively	  non-­‐proliferative.	  The	  same	  can	  be	  said	  for	  the	  A172	  cells,	  as	  they	  were	  also	  
relatively	  non-­‐proliferative,	  with	  a	  stronger	  result	  from	  the	  Control	  group.	  On	  the	  other	  hand	  





5	   10	   15	   20	   25	   Control	  
Cells	  Expressing	  
BrdU	  
(%	  of	  Total)	  
Concentration	  of	  Mitomycin	  (ug/mL)	  
BrdU	  Staining	  Data	  
NIH/3T3	  PANC1	  A172	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4.8.3	  Mitomycin	  Scratch	  Assay	  
	   Each	  of	  the	  three	  cell	  types	  were	  imaged	  over	  a	  period	  of	  50	  hours,	  and	  the	  results	  of	  
this	  assay	  can	  be	  seen	  in	  Figure	  4.14	  through	  Figure	  4.19	  below.	  	  
	  
	  





Figure	  4.15:	  NIH/3T3	  Scratch	  Assay	  50	  Hours	  
	  
	  






Figure	  4.17:	  PANC-­‐1	  Scratch	  Assay	  50	  Hours	  
	  
	  






Figure	  4.19:	  A172	  Scratch	  Assay	  50	  Hours	  
	  
This	  experiment	  determined	  that	  over	  a	  period	  of	  50	  hours,	  mitomycin	  treated	  PANC-­‐1	  cells	  
migrate	  the	  farthest	  distance	  of	  approximately	  500	  μm.	  A172	  cells	  migrated	  a	  total	  of	  300	  μm,	  
while	  NIH/3T3	  cells	  migrated	  only	  200	  μm.	  




Chapter	  5:	  Design	  Verification	  Results	  
	   Following	  the	  completion	  of	  successful	  feasibility	  studies,	  the	  group	  began	  testing	  the	  
prototypes	  of	  the	  migration	  and	  capture	  devices.	  The	  data	  of	  these	  tests	  are	  presented	  here.	  
5.1	  Preliminary	  Results	  –	  Migration	  Device	  
	   After	  initial	  modeling	  and	  feasibility	  experiments	  were	  performed,	  the	  second	  iteration	  of	  devices	  were	  used	  to	  form	  barriers	  using	  collagen.	  	  It	  was	  quickly	  noted	  that	  the	  barriers	  were	  extremely	  unstable	  and	  difficult	  to	  form	  without	  failure.	  	  The	  uncrosslinked	  collagen	  acted	  much	  more	  viscous	  than	  the	  water	  that	  was	  used	  during	  initial	  tests.	  After	  a	  number	  of	  attempts	  to	  make	  barriers	  in	  the	  devices,	  3	  main	  outcomes	  were	  identified:	  1:	  A	  successful	  continuous	  barrier	  is	  formed	  as	  expected	  with	  no	  collagen	  leaking	  from	  the	  channel.	  2:	  A	  continuous	  barrier	  is	  formed,	  but	  collagen	  begins	  to	  leak	  at	  some	  point,	  causing	  a	  section	  of	  the	  barrier	  to	  be	  extremely	  wide.	  3:	  The	  barrier	  fails	  to	  flow	  all	  the	  way	  to	  the	  outlet	  channel,	  or	  fills	  the	  entire	  chamber	  around	  the	  barrier	  channel.	  These	  scenarios	  can	  be	  seen	  in	  Figure	  5.1.	  This	  is	  usually	  due	  to	  one	  of	  two	  failure	  mechanisms	  of	  the	  barrier.	  The	  first	  is	  a	  phenomenon	  where,	  as	  the	  collagen	  flow	  reaches	  the	  entrance	  to	  the	  barrier	  channel,	  it	  begins	  to	  “grab”	  onto	  the	  walls	  of	  the	  chamber	  before	  it	  “grabs”	  the	  barrier	  posts.	  This	  causes	  a	  large	  bulge	  of	  collagen	  to	  form	  that	  usually	  expands	  when	  pressure	  is	  applied,	  preventing	  the	  collagen	  from	  continuing	  to	  flow	  through	  the	  barrier	  channel.	  The	  second	  failure	  identified	  is	  simply	  a	  failure	  of	  the	  surface	  tension	  of	  the	  collagen	  solution	  to	  hold	  it	  between	  the	  barrier	  posts.	  This	  results	  in	  a	  bulge	  of	  collagen	  forming	  somewhere	  along	  the	  barrier	  and	  then	  expanding	  to	  fill	  the	  chamber.	  Often	  the	  pressure	  failure	  can	  be	  caused	  by	  a	  blockage	  in	  the	  barrier	  channel	  that	  causes	  
51	  
	  
back	  pressure	  in	  the	  system.	  Square	  barrier	  posts	  also	  performed	  better	  than	  rotated	  or	  regular	  posts.	  	  The	  devices	  that	  performed	  with	  the	  least	  failures	  were	  ones	  with	  100um	  barrier	  post	  spacing,	  and	  1mm	  barrier	  length.	  	  	  Successful	  Barrier	   Successful	  Barrier	  with	  Defect	  
	   	  Pressure	  Failure	   Wall-­‐Grab	  Failure	  
	   	  
Figure	  5.1	  -­‐	  Possible	  outcomes	  of	  hydrogel	  barrier	  formation	  
  
 After	  a	  successful	  1mm	  barrier	  was	  formed,	  it	  was	  allowed	  to	  crosslink	  in	  an	  incubator	  at	  37C	  overnight	  and	  cells	  were	  seeded	  onto	  the	  barrier	  by	  flowing	  a	  cell	  suspension	  of	  1million	  cells/mL	  along	  the	  left	  side	  of	  the	  barrier.	  	  The	  hydrogel	  barrier	  was	  imaged	  before	  cell	  seeding,	  shown	  in	  Figure	  5.2.	  The	  two	  bubbles	  on	  either	  side	  of	  the	  barrier	  occurred	  during	  the	  hydrogel	  barrier	  formation	  and	  did	  not	  affect	  the	  performance	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of	  the	  barrier.	  Cells	  can	  be	  seen	  in	  the	  barrier	  in	  Figure	  5.3	  immediately	  after	  being	  seeded	  from	  the	  chamber	  on	  the	  left.	  Figure	  5.4	  shows	  cells	  in	  the	  hydrogel	  24	  hours	  after	  initial	  seeding.	  Figure	  5.5	  shows	  cells	  in	  the	  hydrogel	  72	  hours	  after	  initial	  seeding.	  By	  this	  point,	  a	  void	  in	  the	  collagen	  is	  visible	  between	  the	  2nd	  and	  3rd	  Hydrogel	  Retention	  Posts	  on	  the	  left	  side.	  Cells	  are	  visible	  in	  this	  void,	  as	  well	  as	  “upward”	  into	  the	  hydrogel.	  	  Little	  to	  no	  migration	  of	  the	  cells	  was	  observed	  over	  the	  course	  of	  72	  hours.	  	  Cells	  that	  were	  initially	  in	  the	  barrier	  did	  not	  display	  a	  net	  movement	  in	  any	  direction.	  	  After	  72	  hours,	  the	  cells	  began	  to	  die	  due	  to	  lack	  of	  media,	  and	  the	  experiment	  was	  stopped.	  
	  





Figure	  5.4	  -­‐	  Hydrogel	  barrier	  24	  hours	  after	  seeding	  	  	  	  	  	  	  Figure	  5.5	  -­‐	  Hydrogel	  barrier	  72	  hours	  after	  seeding	  	  
5.2	  Preliminary	  Results	  –	  Capture	  Device	  
 In order to test the single cell capture device, PANC-1 cells were diluted in suspension to 




Figure	  5.6	  -­‐	  100um	  Microwell	  Array	  0	  hours	  after	  Seeding	  
	  
	  
Figure	  5.7	  -­‐	  50um	  Microwell	  array	  0	  Hours	  after	  Seeding	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Chapter	  6:	  Discussion	  
	   Here	  the	  group	  presents	  the	  analysis	  of	  results	  from	  device	  fabrication,	  hydrogel	  barrier	  
formation	  testing	  in	  4	  millimeter	  and	  1	  millimeter	  devices,	  as	  well	  as	  the	  initial	  data	  from	  single	  
cell	  capture	  tests.	  
6.1	  Microfluidic	  Device	  Fabrication	  
	   The	  initial	  designs	  the	  group	  created	  contained	  many	  dimensions	  less	  than	  100	  μm;	  
such	  as	  the	  width	  of	  the	  hydrogel	  retention	  posts	  and	  single	  cells	  capture	  wells.	  Due	  to	  the	  
microfluidic	  device	  fabrication	  process,	  these	  features	  were	  often	  not	  developed.	  The	  last	  step	  
of	  the	  fabrication	  process	  involves	  SU-­‐8	  developer	  washing	  away	  all	  un-­‐cross-­‐linked	  
photoresist.	  In	  the	  case	  of	  the	  hydrogel	  retention	  posts,	  the	  developer	  must	  wash	  out	  a	  hole	  in	  
the	  photoresist,	  so	  the	  PDMS	  can	  fill	  it	  in,	  creating	  a	  post.	  The	  retention	  posts	  of	  the	  first	  
iteration	  of	  devices	  were	  not	  properly	  developed,	  and	  the	  devices	  were	  unable	  to	  meet	  any	  of	  
the	  desired	  functions.	  This	  failure	  to	  fabricate	  posts	  can	  be	  seen	  in	  the	  cross	  sectional	  pictures	  
shown	  previously.	  
	  	   In	  the	  second	  iteration	  of	  devices,	  these	  small	  dimensions	  were	  changed	  so	  that	  the	  
hydrogel	  retention	  posts	  could	  be	  properly	  developed.	  In	  addition	  to	  altering	  crucial	  
dimensions,	  the	  height	  at	  which	  the	  photoresist	  was	  crated	  was	  also	  changed.	  In	  devices	  with	  
higher	  photoresist	  heights,	  such	  as	  the	  first	  iterations,	  it	  is	  more	  difficult	  for	  the	  developer	  to	  
create	  full	  3D	  features.	  By	  shortening	  the	  height	  of	  the	  photoresist,	  it	  is	  much	  easier	  for	  the	  
developer	  to	  wash	  away	  all	  un-­‐cross-­‐linked	  photoresist	  to	  form	  full	  3D	  hydrogel	  retention	  
posts.	  These	  full	  hydrogel	  retention	  posts	  can	  be	  seen	  in	  the	  cross	  sections	  of	  the	  second	  
iteration	  devices	  shown	  previously.	  	  
	   It	  is	  also	  important	  to	  note	  that	  during	  the	  development	  of	  the	  first	  iteration	  devices,	  
the	  developer	  was	  left	  on	  the	  wafer	  in	  an	  attempt	  to	  fully	  develop	  the	  hydrogel	  retention	  posts.	  
As	  a	  result	  of	  this,	  the	  more	  sensitive	  features	  such	  as	  micro-­‐wells	  were	  overdeveloped.	  In	  
order	  to	  create	  a	  PDMS	  well,	  a	  photoresist	  post	  must	  be	  created	  to	  form	  a	  negative	  mold.	  With	  
excessive	  exposure	  to	  the	  SU-­‐8	  developer,	  these	  photoresist	  posts	  begin	  to	  get	  worn	  down,	  
materializing	  in	  micro	  wells	  without	  full	  the	  proper	  depth.	  This	  is	  evidenced	  by	  the	  cross	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sections	  of	  initial	  micro-­‐wells	  shown	  above.	  As	  with	  the	  hydrogel	  retention	  posts,	  reducing	  the	  
height	  of	  the	  photoresist	  allowed	  for	  proper	  development,	  as	  seen	  in	  the	  cross	  sectional	  photos	  
of	  the	  second	  iteration	  of	  micro-­‐wells	  shown	  previously.	  
6.2	  Hydrogel	  Barrier	  Formation	  
	   The	  results	  from	  flowing	  liquid	  collagen	  through	  the	  early	  iteration	  barrier	  devices	  were	  
shown	  previously.	  These	  devices	  failed	  to	  create	  full	  3D	  barriers	  in	  a	  majority	  of	  the	  tests.	  The	  
two	  main	  modes	  of	  failure	  of	  the	  barriers	  were	  leakage	  in	  between	  hydrogel	  retention	  posts,	  or	  
wall	  grabbing	  along	  the	  horizontal	  PDMS	  sections	  of	  the	  cell	  chamber.	  Additionally,	  many	  
barriers	  that	  were	  formed	  and	  cured	  successfully	  were	  then	  destroyed	  during	  removal	  of	  inlet	  
blocking	  posts,	  or	  during	  the	  cell	  seeding	  process.	  
	   Liquid	  hydrogel	  was	  able	  to	  flow	  out	  from	  in	  between	  the	  hydrogel	  retention	  posts	  for	  
two	  reasons.	  First,	  the	  posts	  were	  often	  far	  enough	  apart	  that	  the	  surface	  tension	  was	  not	  able	  
to	  hold	  the	  collagen	  back.	  Second,	  the	  barrier	  channel	  was	  too	  long,	  and	  as	  the	  leading	  edge	  of	  
liquid	  collagen	  advanced	  down	  the	  posts,	  higher	  and	  higher	  pressure	  was	  required.	  This	  
resulted	  in	  increased	  pressure	  near	  the	  origin	  of	  the	  barrier,	  and	  this	  was	  often	  the	  site	  of	  
leakage	  from	  in	  between	  posts.	  In	  order	  to	  reduce	  the	  frequency	  of	  these	  failures	  in	  the	  final	  
design,	  the	  overall	  length	  of	  the	  barrier	  was	  reduced,	  and	  the	  distance	  between	  hydrogel	  
retention	  posts	  was	  minimized	  while	  still	  allowing	  space	  for	  cells	  to	  pass	  through.	  
	   	  A	  frequent	  failure	  mode	  for	  many	  hydrogel	  barrier	  devices	  was	  large	  bubbles	  of	  liquid	  
hydrogel	  flowing	  into	  the	  large	  cell	  and	  chemoattractant	  areas.	  This	  was	  caused	  by	  the	  
hydrogel	  adhering	  to	  the	  wall	  of	  the	  cell	  of	  chemoattractant	  chamber	  rather	  than	  the	  hydrogel	  
retention	  posts.	  Because	  the	  wall	  formed	  a	  90-­‐degree	  angle	  with	  the	  barrier	  channel,	  the	  
resultant	  hydrogel	  bubble	  formed	  only	  a	  quarter	  circle,	  greatly	  reducing	  the	  surface	  tension.	  
The	  group	  found	  that	  these	  quarter	  circle	  bubbles	  were	  much	  less	  effective	  at	  resisting	  leakage.	  
In	  order	  to	  reduce	  wall	  grabbing	  in	  the	  final	  device,	  the	  walls	  of	  the	  cell	  and	  chemoattractant	  
chambers	  were	  recessed	  so	  the	  liquid	  hydrogel	  was	  unable	  to	  contact	  it.	  
	   In	  the	  rare	  occasion	  that	  the	  first	  or	  second	  iteration	  devices	  produced	  3D	  hydrogel	  
barriers	  they	  were	  very	  likely	  to	  be	  destroyed	  during	  the	  removal	  of	  the	  inlet/outlet	  blocking	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posts.	  These	  blocking	  posts	  were	  placed	  into	  the	  inlets	  and	  outlets	  of	  the	  device	  in	  order	  to	  
better	  contain	  the	  hydrogel	  barrier	  by	  increasing	  pressure	  on	  either	  side.	  After	  the	  hydrogel	  
was	  cured,	  these	  posts	  needed	  to	  be	  removed	  in	  order	  to	  flow	  in	  cells	  and	  chemoattractant	  
agents.	  However,	  the	  process	  of	  removing	  the	  posts	  created	  a	  small	  vacuum	  inside	  the	  device.	  
In	  most	  cases,	  the	  hydrogel	  barrier	  was	  unable	  to	  sustain	  the	  force	  of	  this	  pressure	  difference,	  
and	  was	  destroyed.	  The	  method	  for	  creating	  hydrogel	  barriers	  in	  the	  final	  design	  must	  be	  
altered	  to	  eliminate	  the	  need	  for	  these	  inlet/outlet	  blocking	  posts.	  
6.3	  Cell	  Migration	  Through	  Barrier	  
	   The	  one	  instance	  that	  the	  hydrogel	  was	  formed	  successfully	  and	  maintained	  its	  
structural	  stability	  during	  the	  curing	  process,	  the	  device	  was	  seeded	  with	  cells.	  The	  results	  of	  
this	  test	  have	  been	  shown	  previously.	  Overall,	  the	  device	  failed	  to	  induce	  migration	  of	  
metastatic	  cancer	  cells	  through	  the	  barrier.	  This	  was	  due	  to	  a	  major	  flaw	  in	  the	  device	  design.	  
The	  large	  cell	  and	  chemoattractant	  chambers	  on	  the	  left	  and	  right	  of	  the	  barrier	  made	  it	  very	  
difficult	  to	  seed	  cells	  directly	  in	  contact	  with	  the	  barrier.	  Similarly,	  it	  was	  nearly	  impossible	  to	  
flow	  the	  chemoattractant	  in	  contact	  with	  the	  opposite	  side	  of	  the	  barrier.	  Because	  of	  this,	  the	  
design	  failed	  to	  create	  a	  chemoattractant	  gradient	  for	  cell	  migration.	  For	  the	  final	  design,	  the	  
group	  must	  eliminate	  the	  large	  cell	  and	  chemoattractant	  chambers,	  and	  develop	  a	  method	  for	  
seeding	  cells	  and	  media	  directly	  along	  the	  hydrogel	  barrier.	  
6.4	  Single	  Cell	  Capture	  
	   Due	  to	  the	  development	  problems	  of	  the	  first	  iteration	  of	  devices,	  only	  the	  100	  μm	  and	  
50	  μm	  formed	  useable	  devices.	  However,	  as	  a	  result	  of	  overdevelopment,	  both	  sets	  of	  wells	  
were	  oversized,	  and	  in	  many	  cases	  were	  touching.	  These	  wells	  were	  capable	  of	  capturing	  cells,	  
however	  often	  captured	  multiple	  cells.	  This	  problem	  was	  due	  to	  both	  the	  large	  size	  of	  the	  wells,	  
and	  the	  high	  seeding	  density	  used.	  For	  the	  final	  design,	  the	  wells	  had	  a	  smaller	  diameter,	  and	  
the	  cell	  suspension	  was	  less	  less	  dense	  to	  increase	  the	  likelihood	  of	  single	  cell	  capture.	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6.5	  Design	  Considerations	  
	   In	  this	  section	  the	  team	  discusses	  the	  economic,	  environmental,	  societal,	  political,	  
ethical,	  health	  and	  safety,	  manufacturability,	  and	  sustainability	  issues	  the	  team	  foresees	  for	  this	  
project	  and	  the	  device.	  
6.5.1	  Economics	  
	   With	  further	  experimentation	  and	  revision,	  this	  design	  could	  become	  a	  patented	  device	  
used	  for	  migration	  assays	  of	  cancer	  cells.	  The	  device	  would	  provide	  an	  alternative	  to	  current	  
techniques	  of	  diagnosing	  tumors	  as	  malignant	  versus	  benign.	  Additionally,	  the	  device	  could	  be	  
one	  of	  the	  first	  used	  to	  provide	  patient-­‐to-­‐patient	  personalized	  cancer	  treatment.	  Each	  biopsy	  
could	  be	  analyzed	  and	  the	  proper	  drug	  could	  be	  administered.	  
6.5.2	  Environmental	  Impact	  
	   The	  hydrogel	  and	  PDMS	  used	  to	  create	  the	  devices	  is	  biodegradable	  and	  non-­‐toxic	  and	  
does	  not	  pose	  an	  environmental	  threat.	  The	  use	  of	  cancer	  cells	  in	  the	  device	  will	  remain	  safe	  so	  
long	  as	  the	  device	  is	  kept	  in	  a	  lab	  and	  proper	  safety	  precautions	  are	  taken.	  The	  manufacture	  of	  
the	  silicon	  wafer	  necessary	  for	  device	  fabrication	  requires	  the	  use	  of	  toxic	  chemicals	  SU-­‐8	  
developer	  and	  TFOCS.	  These	  chemicals	  should	  not	  pose	  an	  environmental	  threat	  as	  long	  as	  they	  
are	  used	  in	  a	  proper	  fume	  hood.	  
6.5.3	  Societal	  Influence	  
	   Ideally,	  the	  device	  will	  be	  used	  to	  learn	  more	  about	  cancer	  cell	  metastasis,	  as	  well	  as	  
develop	  personalized	  medicine	  techniques	  based	  on	  drug	  efficacy	  studies.	  If	  this	  is	  successful,	  
the	  number	  of	  cancer-­‐related	  mortalities	  can	  decrease,	  and	  the	  overall	  health	  of	  the	  population	  
can	  increase.	  
6.5.4	  Political	  Ramifications	  
	   With	  the	  possibility	  to	  revolutionize	  the	  field	  of	  cancer	  research	  as	  well	  as	  that	  of	  
personalized	  medicine,	  there	  are	  many	  stakeholders	  on	  either	  side.	  If	  the	  device	  is	  successful,	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current	  methods	  could	  become	  obsolete	  and	  stakeholders	  in	  these	  methods	  could	  lose	  
influence.	  	  
6.5.5	  Ethical	  Concerns	  
	   With	  the	  primary	  use	  of	  this	  device	  being	  cancer	  cell	  migration	  research	  and	  prevention,	  
the	  ethical	  concerns	  will	  be	  minimal.	  However,	  the	  possibility	  of	  using	  a	  single	  cell	  capture	  
device	  for	  other	  purposes	  such	  as	  stem	  cell	  research	  or	  genetics	  could	  be	  more	  controversial.	  
The	  ethics	  of	  these	  types	  of	  studies	  must	  be	  dealt	  with	  on	  a	  case-­‐by-­‐case	  basis.	  
6.5.6	  Health	  and	  Safety	  Issues	  
	   Because	  the	  device	  will	  be	  primarily	  used	  with	  highly	  aggressive	  cancer	  cells,	  proper	  lab	  
technique	  and	  personal	  protection	  equipment	  must	  be	  used	  at	  all	  times.	  All	  cell	  culture	  
operations	  must	  be	  performed	  inside	  a	  biosafety	  hood,	  and	  then	  transferred	  to	  an	  incubator.	  
After	  the	  experiment	  is	  concluded,	  the	  device	  should	  be	  cleaned	  using	  10%	  bleach	  to	  kill	  any	  
remaining	  cells.	  The	  glass	  slide	  of	  the	  device	  should	  be	  disposed	  of	  properly	  to	  prevent	  injury.	  
6.5.7	  Manufacturability	  
	  
	   The	  device	  could	  be	  manufactured	  as	  used	  in	  this	  project;	  a	  PDMS	  mold	  bonded	  to	  a	  
glass	  slide.	  The	  device	  would	  be	  packaged	  in	  this	  form,	  and	  individual	  users	  would	  form	  the	  
hydrogel.	  This	  manufacturing	  method	  would	  result	  in	  the	  most	  stable	  devices,	  and	  in	  the	  
greatest	  numbers.	  Alternatively,	  the	  device	  could	  be	  packaged	  and	  shipped	  following	  formation	  
of	  the	  hydrogel.	  Using	  this	  method,	  some	  devices	  would	  be	  wasted	  due	  to	  unsuccessful	  
hydrogel	  barriers,	  though	  all	  devices	  received	  by	  the	  user	  would	  be	  fully	  functional.	  For	  either	  
method	  to	  be	  effective,	  the	  photolithography	  process	  would	  need	  to	  be	  revamped	  to	  produce	  
more	  devices	  per	  batch.	  
6.5.8	  Sustainability	  
	   The	  glass	  slides	  and	  PDMS	  used	  to	  fabricate	  the	  devices	  are	  readily	  available.	  The	  
collagen	  hydrogel	  used	  to	  create	  the	  hydrogel	  barrier	  is	  soured	  naturally	  and	  so	  depends	  on	  the	  
harvesting	  from	  sources.	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6.6	  Financial	  Considerations	  
	   In	  this	  section	  the	  team	  analyses	  the	  full	  cost	  of	  production	  of	  a	  single	  microfluidic	  
device.	  This	  includes	  the	  cost	  to	  manufacture	  a	  silicon	  wafer	  mold	  and	  the	  hydrogel	  barrier.	  The	  
cost	  to	  produce	  a	  single	  wafer	  mold	  is	  outlined	  below	  in	  Table	  6.1.	  	  	  
Table	  6.1:	  Cost	  to	  Produce	  a	  Single	  Silicon	  Wafer	  Mold	  
	   Based	  on	  this	  pricing	  information,	  the	  total	  cost	  to	  produce	  a	  wafer	  mold	  is	  
approximately	  $65.	  It	  should	  be	  noted	  that	  once	  a	  wafer	  is	  produced,	  it	  can	  be	  used	  to	  produce	  
a	  large	  number	  of	  actual	  devices,	  thereby	  reducing	  the	  cost	  per	  device	  of	  the	  wafer.	  Next,	  the	  
cost	  of	  forming	  the	  PDMS	  device	  complete	  with	  hydrogel	  barrier	  and	  FBS	  gradient	  was	  
calculated.	  This	  information	  can	  be	  seen	  in	  Table	  6.2.	  
PDMS	  Device	  Costs	  
Material	   Unit	   Cost	   Units	  used	   Total	  Cost	  
PDMS	   1.1	  lb	   $60.00	   .018	  lb	   $0.98	  
Glass	  Slide	   72	   $5.60	   1	   $0.08	  
Media	   500	  mL	   $30.00	   2	  mL	   $0.12	  
Collagen	   35	  mL	   $320.00	   1	  mL	   $9.14	  
FBS	   50	  mL	   $39.00	   .33	  mL	   $0.26	  
Table	  6.2:	  Costs	  to	  Produce	  a	  Single	  PDMS	  Device	  
Silicon	  Wafer	  Costs	  
Material	   Unit	   Cost	   Units	  used	   Total	  Cost	  
Photomask	   1	   $20.00	   1	   $20	  
Silicon	  Wafer	   10	   $300.00	   1	   $30	  
SU-­‐8	  Photoresist	   1	  Liter	   $600.00	   .01	  L	   $6	  
SU-­‐8	  Developer	   1	  Liter	   $450.00	   .02	  L	   $9	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   Based	  on	  these	  pricing	  calculations,	  the	  cost	  to	  produce	  a	  PDMS	  device	  complete	  with	  
hydrogel	  barrier	  and	  FBS	  gradient	  is	  $10.58.	  This	  price	  does	  not	  include	  the	  cost	  of	  producing	  
the	  initial	  wafer,	  because	  many	  multiple	  devices	  can	  be	  molded	  from	  the	  wafer,	  effectively	  
reducing	  the	  cost	  per	  device.	  
	   	  
62	  
	  
Chapter	  7:	  Final	  Design	  and	  Validation	  
	   Here	  the	  group	  presents	  the	  final	  design	  of	  the	  device	  known	  as	  the	  X-­‐Design.	  Also	  
presented	  are	  the	  final	  versions	  of	  the	  single	  cell	  capture	  wells.	  	  The	  team	  also	  presents	  the	  
results	  from	  the	  testing	  of	  these	  final	  designs.	  
7.1	  Final	  Iteration	  Migration	  Device,	  X-­‐Design	  
After having several failures during the fabrication of hydrogel barriers with the previous 
designs, the team determined there were several changes that could be made to the devices to 
improve them. Figure 7.1 shows the standard design for the final iteration. The other	  variant of 
this design has one 200 µm gap and no retention posts.	  
 
The most notable feature of this device is its angled channels for the chemotactic agent 
and cell loading channels as shown in Figure 7.2. By angling the channels and reducing the size 
of the cell containment area, it allows for both the chemotactic agent and the cell suspension to 
Figure	  7.1:	  Migration	  Device,	  Final	  Design:	  X-­‐Design	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be immediately seeded onto the hydrogel barrier. In previous designs, the cells would enter the 
rectangular chamber to the left of the hydrogel, and then just flow out of the inlet without ever 
reaching the barrier. This allows for guaranteed access to the chemotactic agent for each cell on 
the left of the barrier. 
Figure	  7.2:	  X-­‐Design	  Close	  Up 
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7.2	  Single	  Cell	  Capture	  Final	  Iteration	  
Our	  initial	  attempts	  at	  single	  cell	  capture	  proved	  difficult	  due	  to	  problems	  with	  
developing	  the	  smaller	  features.	  In	  order	  to	  overcome	  this,	  the	  second	  design	  included	  circular	  
wells	  that	  were	  spaced	  150	  µm	  apart	  regardless	  of	  well	  dimension.	  Figure	  7.3	  shows	  the	  more	  
successful	  single	  cell	  capture	  device	  containing	  30	  µm	  diameter	  wells.	  The	  team	  also	  tested	  50	  
µm,	  40	  µm,	  and	  20	  µm	  circular	  wells.	  It	  was	  determined	  that	  circular	  wells	  would	  be	  more	  
efficient	  than	  the	  previous	  designs	  square	  wells,	  because	  cells	  are	  roughly	  spherical.	  
Figure	  7.3:	  Capture	  Device,	  Final	  Design	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7.3	  X-­‐Design	  Validation	  
	   Following	  the	  testing	  of	  the	  initial	  iterations,	  the	  design	  was	  revised	  as	  previously	  
outlined.	  Presented	  here	  are	  the	  results	  from	  further	  testing	  of	  the	  final	  iterations	  of	  the	  
hydrogel	  barrier	  device.	  
7.3.1	  Hydrogel	  Barrier	  Formation	  
	   The	  revised	  design	  was	  profoundly	  more	  effective	  at	  producing	  a	  successful	  hydrogel	  
barrier	  compared	  with	  the	  first	  two	  iterations.	  The	  liquid	  hydrogel	  was	  contained	  within	  the	  
barrier	  channel	  during	  90%	  (9	  of	  10)	  of	  trials.	  This	  represents	  a	  substantial	  increase	  in	  the	  
efficacy	  of	  the	  device,	  and	  meets	  the	  primary	  function	  of	  forming	  a	  3D	  hydrogel	  barrier.	  The	  
hydrogel	  formation	  process	  can	  be	  seen	  in	  Figure	  7.4	  through	  Figure	  7.5.	  
	  
	  	  	  	  	  	  	  	  	  	  	  Figure	  7.4:	  X-­‐Design	  Barrier	  Formation	  Step	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Figure	  7.5:	  X-­‐Design	  Barrier	  Formation	  Step	  2	  
Figure	  7.4	  shows	  the	  liquid	  collagen	  flowing	  into	  the	  device	  from	  the	  top	  inlet.	  The	  collagen	  has	  
reached	  the	  first	  void	  and	  is	  bubbling	  out	  in	  all	  directions	  equally.	  Based	  on	  the	  precise	  
dimensions	  and	  geometries	  of	  the	  design,	  the	  liquid	  collagen	  adheres	  to	  the	  hydrogel	  retention	  
post,	  seen	  in	  Figure	  7.5.	  Due	  to	  capillary	  action,	  the	  collagen	  is	  drawn	  through	  the	  barrier	  
channel,	  while	  not	  leaking	  out	  from	  in	  between	  the	  posts.	  Also,	  the	  surface	  tension	  of	  the	  liquid	  




	   Figure	  7.6:	  X-­‐Design	  Barrier	  Formation	  Step	  3	  	  	  	   Figure	  7.7:	  X-­‐Design	  Barrier	  Formation	  Step	  4	  
	   While	  the	  pressure	  is	  held	  constant,	  the	  liquid	  hydrogel	  continues	  through	  the	  barrier	  
channel.	  Figure	  7.6	  shows	  the	  hydrogel	  bubbling	  out	  in	  all	  directions	  similar	  to	  the	  process	  that	  
occurred	  at	  the	  first	  void.	  Finally,	  the	  collagen	  forms	  a	  full	  barrier	  by	  capillary	  action	  in	  Figure	  
7.7.	  
	   The	  X-­‐Design	  was	  able	  to	  stop	  the	  phenomenon	  of	  wall	  grabbing	  seen	  in	  the	  previous	  
devices.	  In	  the	  10	  devices	  tested,	  0	  failed	  due	  to	  wall	  grabbing.	  Additionally,	  the	  distance	  
between	  the	  hydrogel	  retention	  posts	  was	  able	  to	  properly	  contain	  the	  liquid	  hydrogel	  long	  
enough	  for	  it	  to	  cure.	  180-­‐degree	  bubbles	  of	  liquid	  collagen	  can	  be	  seen	  above,	  being	  retained	  
by	  their	  own	  surface	  tension.	  Capillary	  action	  was	  also	  effective	  at	  drawing	  the	  liquid	  collagen	  
down	  through	  the	  hydrogel	  outlet,	  to	  form	  a	  full	  3D	  barrier.	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7.3.2	  Cell	  Migration	  Through	  Barrier	  
	   Following	  successful	  hydrogel	  barrier	  formations,	  cells	  were	  seeded	  along	  the	  left	  side	  
of	  the	  device	  as	  outlined	  previously.	  Figure	  5	  shows	  the	  same	  barrier	  from	  Figure	  4,	  but	  at	  a	  
higher	  magnification.	  Cells	  can	  be	  seen	  along	  the	  left	  side	  of	  the	  barrier,	  as	  well	  as	  in	  the	  
barrier.	  These	  cells	  that	  are	  in	  the	  barrier	  arrived	  there	  during	  the	  seeding	  process	  due	  to	  
pressure	  differences.	  While	  this	  should	  issue	  should	  be	  resolved	  for	  future	  use,	  it	  did	  not	  affect	  
the	  validity	  of	  the	  data	  collected.	  At	  t	  =	  0	  hours,	  two	  single	  cells	  can	  be	  seen	  near	  the	  hydrogel	  
retention	  post	  on	  the	  left,	  as	  well	  as	  near	  the	  post	  on	  the	  right.	  The	  red	  circles	  in	  Figure	  7.8	  
highlight	  these	  cells.	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The	  cells	  were	  then	  imaged	  frequently	  to	  monitor	  their	  migration.	  At	  t	  =	  14	  hours,	  the	  
single	  cell	  originally	  located	  in	  the	  circle	  on	  the	  left	  has	  migrated	  down	  and	  to	  the	  right	  in	  
response	  to	  the	  FBS	  chemical	  gradient.	  By	  contrast,	  the	  cell	  in	  the	  circle	  on	  the	  right	  has	  not	  
migrated	  at	  all	  but	  rather	  has	  begun	  to	  proliferate.	  Figure	  7.9	  depicts	  this	  contrast	  between	  the	  
migratory	  cell	  on	  the	  left	  and	  the	  non-­‐migratory	  cell	  on	  the	  right.	  
	  
Figure	  7.9:	  PANC1	  Cells	  in	  Hydrogel	  Barrier,	  14	  Hours	  














At	  t	  =	  22	  hours,	  the	  migratory	  cell	  on	  the	  left	  has	  continued	  its	  migration	  down	  and	  to	  
the	  right	  as	  seen	  in	  Figure	  7.10.	  Again,	  in	  contrast,	  the	  non-­‐migratory	  cell	  on	  the	  right	  has	  not	  
been	  able	  to	  move	  through	  the	  barrier,	  and	  as	  a	  result	  has	  proliferated	  in	  the	  same	  area	  shown	  
by	  the	  red	  circle.	  This	  is	  proof	  of	  concept	  data	  that	  the	  group’s	  device	  is	  capable	  of	  
distinguishing	  between	  metastatic	  cancer	  cells	  and	  non-­‐metastatic	  ones.	  The	  more	  metastatic	  
cancer	  cells	  were	  able	  to	  borough	  through	  the	  barrier,	  and	  isolate	  themselves	  based	  on	  their	  
own	  migration.	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7.4	  Single	  Cell	  Capture	  Validation	  
	   In	  order	  to	  validate	  the	  group’s	  final	  design	  for	  single	  cell	  capture,	  the	  procedure	  
outlined	  previously	  was	  followed.	  An	  area	  of	  the	  micro-­‐well	  array	  that	  was	  a	  good	  
representation	  of	  the	  whole	  array	  was	  then	  imaged.	  The	  green	  arrows	  in	  Figure	  7.11	  highlight	  
those	  cells	  that	  do	  not	  contain	  any	  cells	  after	  the	  procedure	  was	  complete.	  For	  this	  test,	  the	  
number	  of	  wells	  containing	  0	  cells	  was	  62%.	  In	  the	  case	  of	  single	  cell	  capture,	  capturing	  no	  cells	  
in	  a	  well	  is	  a	  failure.	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In	  addition	  to	  failing	  by	  capturing	  no	  cells,	  the	  single	  cell	  capture	  system	  can	  also	  fail	  by	  
capturing	  more	  than	  one	  cell.	  The	  red	  arrows	  in	  Figure	  7.12	  show	  the	  wells	  that	  captured	  
multiple	  cells	  during	  the	  procedure.	  In	  each	  of	  the	  4	  wells	  shown,	  exactly	  2	  cells	  were	  captured.	  
It	  is	  important	  to	  note	  that	  these	  multiple	  cells	  could	  not	  be	  the	  result	  of	  a	  single	  cell	  being	  
captured	  and	  then	  dividing	  due	  to	  the	  short	  time	  between	  capture	  and	  imaging.	  During	  this	  
study,	  only	  7%	  of	  wells	  failed	  due	  to	  capturing	  multiple	  cells.	  
	  
Figure	  7.12:	  Micro-­‐well	  Array,	  Multiple	  Cells	  











Lastly,	  the	  blue	  arrows	  in	  Figure	  7.13	  show	  all	  the	  wells	  that	  successfully	  captured	  and	  
isolated	  a	  single	  cell.	  In	  this	  experiment,	  over	  30%	  of	  wells	  captured	  single	  cells.	  This	  represents	  
a	  significant	  improvement	  over	  the	  initial	  iterations	  and	  proves	  the	  feasibility	  of	  capturing	  and	  
isolating	  single	  cells	  by	  this	  method.	  
	  








Chapter	  8:	  Conclusions	  and	  Future	  Recommendations	  
	   A	  microfluidic	  device	  for	  the	  capture	  and	  isolation	  of	  metastatic	  cancer	  cells	  has	  been	  
fully	  designed,	  developed,	  and	  prototyped,	  and	  proof	  of	  concept	  data	  has	  been	  collected.	  In	  
this	  section	  the	  group	  summarizes	  the	  achievements	  of	  this	  project	  compared	  with	  the	  initial	  
goals,	  and	  suggests	  means	  and	  methods	  to	  improve	  upon	  the	  design	  for	  future	  works.	  
8.1	  Project	  Conclusions	  
	   The	  initial	  goals	  set	  by	  the	  group	  at	  the	  beginning	  of	  this	  project	  include	  creating	  a	  
basement	  membrane	  mimic	  in	  a	  microfluidic	  device	  using	  a	  hydrogel,	  induce	  migration	  of	  
cancer	  cells	  through	  that	  mimic	  by	  using	  a	  chemoattractant	  agent,	  and	  finally	  capture	  and	  
isolate	  single	  metastatic	  cells	  that	  are	  able	  to	  breach	  the	  barrier.	  
	   Through	  several	  iterations,	  the	  group	  was	  able	  to	  develop	  a	  microfluidic	  design	  that	  was	  
effective	  at	  forming	  microfluidic	  basement	  membrane	  mimics.	  The	  key	  features	  of	  this	  design	  
that	  the	  group	  developed	  include	  recessed	  cell	  chamber	  walls	  in	  order	  to	  prevent	  wall	  
grabbing,	  and	  angled	  channels	  in	  order	  to	  directly	  seed	  cells	  onto	  the	  barrier.	  Additionally,	  
through	  experimentation,	  the	  group	  refined	  the	  method	  of	  forming	  the	  hydrogel	  barrier.	  
Initially,	  many	  barriers	  failed	  due	  to	  a	  flawed	  procedure.	  Flaws	  in	  this	  procedure	  included	  
pressure	  spikes	  upon	  cutting	  the	  hydrogel	  inlet	  tubing,	  and	  the	  creation	  of	  slight	  vacuums	  on	  
either	  side	  of	  the	  barrier	  during	  blocking	  post	  removal.	  This	  procedure	  was	  improved	  to	  include	  
a	  5-­‐minute	  curing	  period	  on	  a	  hot	  plate	  in	  order	  to	  partially	  cure	  the	  gel	  prior	  to	  cutting	  the	  
hydrogel	  inlet	  tube.	  This	  addition	  was	  successful	  in	  greatly	  reducing	  the	  number	  of	  barriers	  that	  
were	  destroyed	  because	  of	  inlet	  tubing	  cutting.	  Lastly,	  the	  group	  revised	  the	  method	  to	  not	  
include	  the	  inlet/outlet	  blocking	  posts,	  thereby	  further	  reducing	  the	  number	  of	  barriers	  that	  
were	  destroyed.	  Overall,	  the	  improvements	  made	  by	  the	  group	  to	  the	  design	  and	  methods	  
resulted	  in	  successful	  basement	  membrane	  mimics	  being	  formed	  in	  90%	  (9	  of	  10)	  of	  tested	  
devices.	  
	   Over	  the	  course	  of	  this	  project,	  migration	  was	  induced	  through	  a	  successful	  hydrogel	  a	  
single	  time.	  Due	  to	  the	  rarity	  of	  successful	  barriers,	  the	  group	  was	  not	  able	  to	  perform	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numerous	  experiments	  on	  the	  migration	  of	  cells	  through	  them.	  Often,	  barriers	  that	  had	  been	  
successfully	  formed	  and	  maintained	  their	  structure	  through	  the	  fabrication	  process	  were	  
destroyed	  during	  the	  seeding	  process	  due	  to	  media	  flowing	  through	  the	  collagen.	  Despite	  these	  
setbacks,	  the	  team	  was	  able	  to	  use	  this	  device	  to	  induce	  migration	  through	  the	  barrier	  in	  the	  
direction	  of	  the	  higher	  chemoattractant	  agent	  concentration.	  	  
	   The	  task	  of	  single	  cell	  capture	  and	  expansion	  is	  a	  particularly	  difficult	  one.	  In	  most	  cases,	  
any	  device	  that	  would	  result	  in	  capturing	  a	  single	  cell	  would	  not	  allow	  any	  room	  for	  expansion.	  
Essentially,	  any	  device	  small	  enough	  to	  capture	  a	  single	  cell	  is	  not	  large	  enough	  to	  allow	  it	  to	  
grow.	  To	  solve	  this	  problem,	  the	  team	  developed	  micro-­‐well	  arrays	  of	  single	  cell	  capture	  wells	  
with	  a	  range	  of	  diameters.	  Although	  the	  initial	  devices	  had	  manufacturing	  issues,	  later	  
iterations	  were	  successfully	  fabricated	  and	  tested.	  Through	  testing,	  the	  team	  identified	  wells	  
with	  a	  30	  μm	  diameter	  as	  the	  most	  successful	  at	  capturing	  single	  cells.	  Wells	  with	  larger	  
diameters	  often	  captured	  multiple	  cells,	  and	  wells	  with	  smaller	  diameters	  captured	  no	  cells	  at	  
all.	  In	  addition	  to	  design	  alterations,	  the	  team	  also	  made	  changes	  to	  the	  method	  of	  seeding	  
cells.	  The	  most	  important	  improvement	  was	  the	  lowering	  of	  the	  density	  of	  cells	  in	  the	  
suspension.	  Overall,	  the	  success	  rate	  of	  the	  team’s	  device	  at	  capturing	  single	  cells	  was	  30%.	  
8.2	  Future	  Recommendations	  
	   In	  the	  future,	  the	  group	  would	  like	  to	  see	  improvements	  made	  to	  the	  design	  and	  
methods	  of	  this	  project	  in	  order	  to	  increase	  the	  efficiency	  and	  produce	  better	  results.	  The	  
group	  believes	  that	  with	  modifications	  and	  future	  testing,	  the	  device	  could	  be	  a	  powerful	  
cancer	  metastasis	  assay	  tool.	  
8.2.1	  3D	  Microfluidics	  
	   The	  use	  of	  complex	  3D	  microfluid	  devices	  gives	  more	  power	  to	  the	  engineer	  to	  create	  
more	  useful	  devices.	  However,	  the	  necessary	  materials	  and	  equipment	  to	  fabricate	  these	  
devices	  is	  very	  expensive,	  and	  well	  outside	  the	  means	  of	  this	  project.	  For	  future	  work,	  the	  team	  
recommends	  exploring	  the	  possibility	  of	  fabricating	  3D	  and	  multilayered	  microfluidic	  devices.	  
By	  using	  these	  types	  of	  devices,	  future	  teams	  would	  be	  able	  to	  combine	  the	  Migration	  Device	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and	  the	  Capture	  Device	  into	  a	  single	  device.	  This	  would	  make	  the	  device	  easier	  to	  use,	  and	  
more	  controlled.	  Alternatively,	  3D	  microfluidics	  open	  up	  more	  possibilities	  for	  increasingly	  
complex	  single	  cell	  capture	  devices.	  The	  group	  originally	  developed	  a	  design	  for	  a	  multilayered	  
device	  that	  would	  capture	  single	  cells	  using	  suction.	  Future	  teams	  could	  use	  3D	  microfluidics	  to	  
prototype	  this	  design	  and	  test	  it.	  
8.2.2	  Develop	  a	  Controlled	  Flow	  System	  
	   When	  fabricating	  the	  hydrogel	  barrier	  inside	  the	  device,	  many	  variables	  can	  affect	  the	  
success	  of	  the	  flow	  and	  the	  integrity	  of	  the	  barrier.	  Currently,	  lowering	  and	  raising	  the	  reservoir	  
syringe	  control	  the	  flow	  of	  collagen	  into	  the	  channel.	  This	  could	  be	  improved	  by	  determining	  
the	  ideal	  flow	  rate	  for	  barrier	  formation	  and	  then	  using	  a	  precise	  syringe	  pump	  to	  ensure	  that	  
the	  flow	  is	  constant.	  Another	  problem	  with	  the	  current	  system	  is	  the	  removal	  of	  the	  inlet	  tube	  
that	  delivers	  the	  collagen	  to	  the	  barrier	  channel.	  The	  current	  standard	  is	  for	  the	  tube	  to	  be	  cut	  
or	  removed	  by	  hand,	  which	  often	  causes	  pressure	  spikes	  inside	  the	  device	  that	  forces	  the	  
collagen	  out	  of	  the	  barrier	  channel.	  To	  solve	  this,	  a	  controlled	  removal	  method	  must	  be	  
developed	  that	  either	  does	  not	  introduce	  extra	  pressure	  to	  the	  system	  or	  relieves	  the	  pressure	  
as	  it	  creates	  it	  so	  as	  not	  to	  disrupt	  the	  hydrogel	  barrier.	  The	  final	  variable	  step	  in	  the	  barrier	  
formation	  process	  is	  the	  application	  of	  heat	  to	  crosslink	  the	  hydrogel	  after	  it	  has	  been	  flowed	  
into	  the	  barrier	  channel.	  The	  current	  method	  is	  to	  remove	  the	  inlet	  tube	  and	  transfer	  the	  
device	  to	  an	  incubator	  for	  90	  minutes.	  This	  movement	  and	  handling	  of	  the	  device	  can	  also	  
disrupt	  the	  hydrogel	  barrier,	  causing	  it	  to	  leak	  out	  from	  between	  the	  hydrogel	  retention	  
posts.	  There	  is	  a	  need	  for	  a	  direct	  heating	  element	  that	  the	  device	  can	  rest	  on	  during	  the	  
flowing	  process	  so	  that	  the	  hydrogel	  can	  be	  immediately	  cross-­‐linked	  under	  heat	  without	  the	  
need	  to	  touch	  or	  move	  the	  device.	  Overall,	  the	  process	  of	  forming	  the	  hydrogel	  barrier	  needs	  to	  
be	  standardized	  once	  the	  optimal	  parameters	  have	  been	  established.	  All	  of	  this	  would	  allow	  for	  
a	  much	  greater	  success	  rate	  when	  forming	  the	  hydrogel	  barriers.	  
8.2.3	  Single	  Cell	  Robotic	  Extraction	  
	   Although	  the	  team	  succeeded	  in	  capturing	  single	  cells,	  there	  is	  still	  a	  need	  for	  a	  method	  
of	  extraction.	  They	  propose	  a	  robotic	  system	  for	  integration	  with	  their	  single	  cell	  capture	  wells.	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The	  robotic	  system	  should	  be	  able	  to	  use	  images	  of	  the	  single	  cell	  capture	  wells,	  either	  
autonomously	  or	  with	  an	  operator,	  to	  determine	  where	  single	  cells	  are	  located.	  Once	  the	  
location	  is	  determined,	  the	  system	  should	  be	  able	  to	  precisely	  extract	  the	  single	  cell	  with	  an	  
affixed	  micropipette,	  punching	  through	  the	  PDMS	  if	  necessary,	  and	  then	  depositing	  them	  in	  a	  
desired	  receptacle	  for	  further	  study	  and	  growth.	  Since	  the	  single	  cell	  capture	  wells	  can	  be	  
redesigned	  at	  different	  dimensions,	  they	  could	  be	  designed	  to	  better	  suit	  the	  need	  of	  the	  
extraction	  method,	  such	  as	  increasing	  the	  distance	  between	  wells	  to	  allow	  for	  more	  space	  for	  
the	  robotic	  arm.	  
8.2.4	  Testing	  of	  Chemoattractant	  Gradient	  
	   Due	  to	  the	  rarity	  of	  successful	  hydrogel	  barriers	  previously	  mentioned,	  the	  group	  was	  
not	  able	  to	  test	  the	  chemoattractant	  agent	  in	  depth.	  Future	  teams	  should	  use	  fluorescently	  
labeled	  proteins	  in	  order	  to	  quantify	  the	  gradient	  formed	  by	  the	  chemoattractant	  agent	  in	  the	  
barrier,	  as	  well	  as	  determine	  how	  often	  the	  media	  should	  be	  changed.	  Further,	  the	  group	  
would	  like	  to	  test	  the	  effect	  of	  different	  types	  of	  chemoattractants	  on	  the	  migration	  of	  cells.	  
Ideally,	  an	  agent	  should	  be	  used	  that	  best	  represents	  the	  characteristics	  in	  vivo.	  
8.2.5	  Validation	  of	  Metastatic	  Markers	  
	   Because	  the	  group	  was	  not	  able	  to	  induce	  a	  cell	  to	  breach	  completely	  through	  the	  
barrier,	  they	  were	  not	  capable	  of	  testing	  the	  migratory	  cells	  for	  metastatic	  gene	  expression.	  
Ideally,	  future	  teams	  would	  be	  able	  to	  run	  large	  numbers	  of	  cells	  through	  the	  device,	  capture	  
migratory	  cells	  that	  have	  breached	  the	  barrier,	  grow	  them	  in	  culture,	  and	  test	  them	  for	  the	  
prevalence	  of	  metastatic	  gene	  expression.	  Based	  on	  the	  group’s	  hypothesis,	  the	  cells	  that	  are	  
able	  to	  breach	  the	  barrier	  will	  have	  a	  higher	  percentage	  of	  metastatic	  markers	  compared	  with	  
the	  larger	  population.	  	  
8.2.6	  Personalized	  Medicine	  
	   The	  team	  believes	  that	  their	  devices	  show	  promise	  for	  clinical	  applications,	  particularly	  
in	  the	  personalized	  medicine	  field.	  Since	  the	  devices	  allow	  for	  the	  separation	  of	  migratory	  
cancer	  cells	  from	  non-­‐migratory	  cancer	  cells,	  it	  would	  be	  feasible	  to	  separate	  migratory	  cancer	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cells	  from	  non-­‐migratory	  cancer	  cells.	  Thus	  if	  you	  took	  a	  biopsy	  of	  a	  tumor,	  you	  could	  use	  the	  
device	  to	  test	  the	  metastatic	  nature	  of	  the	  cancer	  cells	  within	  that	  tumor,	  and	  if	  you	  isolated	  
those	  cells	  with	  the	  single	  cell	  capture	  device,	  you	  could	  then	  test	  which	  drugs	  would	  best	  treat	  
a	  patients	  metastatic	  cancer	  growths.	  Similarly,	  if	  a	  tumor	  does	  prove	  to	  have	  metastatic	  
properties,	  the	  stiffness	  of	  the	  hydrogel	  within	  the	  device	  could	  be	  altered	  to	  reflect	  different	  
tissues	  within	  the	  body.	  This	  could	  give	  doctors	  an	  idea	  of	  where	  a	  patient’s	  cancer	  is	  most	  
likely	  to	  metastasize	  to.	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Basement	  Membrane	  Mimic	   	   A	  hydrogel	  barrier	  that	  resembles	  the	  basement	  	  
	   	   	   	   	   membrane	  found	  in	  vivo.	  	  
Migration	  Device	   	   	   The	  microfluidic	  device	  used	  to	  form	  a	  basement	  	  
	   	   	   	   	   membrane	  mimic	  and	  induce	  migration.	  	  
Capture	  Device	   	   	   	   A	  microfluidic	  device	  used	  to	  capture	  and	  isolate	  	  
	   	   	   	   	   single	  cells.	  
Hydrogel	  Retention	  Posts	   	   Posts	  constructed	  of	  PDMS	  that	  form	  the	  barrier	  	  
	   	   	   	   	   channel	  and	  restrict	  the	  liquid	  hydrogel	  from	  leaking.	  
Wall	  Grabbing	   	   	   	   The	  phenomenon	  of	  liquid	  collagen	  adhering	  to	  the	  	  
	   	   	   	   	   PDMS	  walls,	  creating	  large	  bubbles	  in	  the	  device.	  
Crosslinking	   	   	   	   The	  process	  by	  which	  a	  liquid	  hydrogel	  forms	  	   	  
	   	   	   	   	   covalent	  bonds	  to	  form	  a	  networked	  gel.	  
Hydrogel	   	   	   	   A	  gel	  composed	  of	  polymers	  suspended	  in	  water.	  
Microfluidics	   	   	   	   The	  science	  of	  fluid	  flow	  in	  channels	  of	  micron	  size.	  
PDMS	   	   	   	   	   Polydimethylsiloxane	  is	  a	  frequently	  used	  organic	  	  
	   	   	   	   	   polymer,	  often	  used	  to	  make	  molds.	  
Cell	  Seeding	  (Migration	  Device)	   	   The	  process	  of	  flowing	  a	  cell	  suspension	  into	  a	  	   	  
	   	   	   	   	   microfluidic	  channel	  in	  order	  to	  precisely	  place	  the	  	  
	   	   	   	   	   cells	  along	  the	  hydrogel	  barrier.	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Cell	  Seeding	  (Capture	  Device)	   	   The	  process	  of	  covering	  a	  micro-­‐well	  array	  in	  a	  low	  	  
	   	   	   	   	   density	  cell	  suspension	  and	  allowing	  the	  cells	  to	  	  	  
	   	   	   	   	   settle	  into	  wells.	  
Inlet/Outlet	  Blocking	  Posts	   	   Solid	  metal	  posts	  that	  were	  inserted	  into	  the	  excess	  	  
	   	   	   	   	   inlets	  and	  outlets	  in	  order	  to	  maintain	  pressure	  	  	  
	   	   	   	   	   during	  the	  flowing	  of	  hydrogel.	  
	  




Appendix	  A:	  SOP	  for	  Microfluidic	  Device	  Fabrication	  
Photolithography using SU8 Photoresist 
STANDARD OPERATING PROCEDURE 
 





1. MICROFABRICATION LAB 
Location 
Gateway Park 0122, BME MicroFabrication Laboratory (BME-MFL), WPI  
Access 
Prof. Dirk Albrecht, Dept. of Biomedical Engineering (508-831-4859, dalbrecht@wpi.edu).  
Technical Contact 
Prof. Dirk Albrecht, dalbrecht@wpi.edu 
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2. INTRODUCTION  
Photolithography is a standard procedure to transfer patterns onto the wafers in the 
microfabrication process. This Standard Operating Procedure(SOP) provides information on the 
photolithography process that has been developed at the MicroFabrication Laboratory. There are 
multiple steps involved in the photolithography process: wafer dehydration, photoresist 
spincoat, pre-bake, exposure, post-exposure bake, development, inspection, (optional: 
processing, e.g. etching), and postprocessing (typically hard-bake and fluorination, or resist 
stripping). Each procedure will be discussed in the following sections. Optional processing steps 
are addressed in separate SOPs. 
 
3. LOCATION OF EQUIPMENT, ACCESSORIES, TOOLS, AND SUPPLIES  
The Photoresist Spin Coater (Laurell WS-650MZ-23NPP), UV exposure unit (UV-KUB), hot 
plates (PMC Dataplate 720 and 732), and wafer inspection stereomicroscope (Zeiss Stemi 2000) 
are located in room 0122 of the BME MicroFabrication Laboratory (BME-MFL) in the 
Gateway Park I building at WPI, 60 Prescott St. Currently, the large 10" hotplate for 
dehydration bake (120 ºC) and the UV exposure unit are location in a Labconco cleanhood. The 
two smaller 7" hotplates for pre- and post-bakes (65 ºC and 95 ºC) and the photoresist spinner 
are located opposite in the fume hood. The stereo microscope is located on the stainless steel 




4. PERSONAL SAFETY AND CLEANROOM ATTIRE  
Personal protective equipment including a disposable cleanroom coat and nitrile gloves are 
required for routine operation in this facility. Shoe-covers must be worn before entering the 
room 0122 and are available in the adjacent room 0123. Step on the sticky mat before entering 





5. MATERIAL COMPATIBILITIES  
 
6. PRIMARY HAZARDS AND WARNINGS   
The primary hazards associated with photolithography are the chemicals, including 
photoresists, developer solvents, cleaning and etching solutions including acids and reactive 
chemicals. Therefore, safe chemical handling and storage measures must be adopted. Details on 
chemical storage, handling and disposal are described in the MSDS binder.  
Hotplate temperatures up to 200 ºC may be required with risk of burns.  
UV exposure of photoresists take place within a sealed LED illumination unit and do not pose an 
exposure risk. [However, this is new technology, and be aware that most microfabrication 
facilities use a mercury (Hg) arc lamp a source of ultraviolet radiation during exposure that may 
not be fully enclosed. Ultraviolet radiation can cause burns of the skin or of the outer layers of 
the eye. In these systems, the user must avoid looking directly at the UV source and avoid 
exposure to reflected or diffused UV from the lamp. In addition, an Hg arc lamp operates at high 
voltage and the user should make sure that the power supply and illuminator are covered 
properly, and that cables are properly connected.] 
 
7. OPERATIONAL PROCEDURE CHECKLISTS  
This Standard Operating Procedure(SOP) provides information on the photolithography process 
that has been developed at the MicroFabrication Laboratory. Each step involves using different 
equipment and it is important that user is familiar with the location of the equipment and all of its 
key components. 
 
Preliminary Setup. Determine photolithography parameters  
Before beginning any photolithography process, the entire procedure must be planned. The 
primary determinants to spin speeds and duration of baking and development steps are the 
photoresist material and the desired resist thickness. Refer to the photoresist spec sheets for 
more information, such as, for SU-8 2000 series: http://www.microchem.com/pdf/SU-
82000DataSheet2025thru2075Ver4.pdf 
 
For example, for a 80µm thick process using SU8 2035, we find the following information from 
the datasheet above:  
1. Spin speed: 1600 rpm (Figure 1)   
2. Soft-bake times: 3 min @ 65 °C; 9 min @ 95 °C (Table 2)  
3. Exposure energy: 215 mJ/cm2 (Table 3)   4. Relative dose: 1x (Table 4)   
5. Post-exposure bake: 2 min @ 65 °C; 7 min @ 95 °C (Table 5)  
6. Development time: 7 min (Table 6)  
 
The bake times directly relate to the experimental plan, but the UV exposure time must be 
calculated from the exposure energy, relative dose, the illumination intensity, and an empirical 
correction factor. The illumination intensity of the UV-KUB should be stabel at 23.4 mW/cm2, 
and the correction factor is 1.5 due to the narrow spectrum of UV exposure at 365 nm. For 
example, from the data above, the UV exposure time should be: 




Procedure 1. Dehydration Bake  
The dehydration bake removes residual water 
molecules from the wafer surface by heating up the 
wafer on a hot plate or convection oven. Removing 
residual moisture increases the adhesion of the 
photoresist on the substrate. 
 
This step uses the large 10" PMC Dataplate hot 
plate in the clean hood that can be seen in Figure 1. 
 
Figure 1. Hot plate front panel  
1. Turn on the blower and light on the cleanhood. 
Let it run for a few minutes before working inside.  
2. Power on the PMC Dataplate hot plate in the Figure 1: 10" PMC Dataplate 732 clean hood. Ensure the hotplate surface is clean.  
3. Set the desired temperature to 120 °C. Press the following buttons in order: [SET], "Plate 
Temp" [1], [1], [2], [0], [ENT]. The display cycles between the set temperature and current 
temperature about once per second.   
4. Place a clean new wafer onto the hotplate surface. The whole wafer should   completely fit on the hotplate surface so that heat can 
conduct evenly to the wafer.  5. Once the plate reaches the desired temperature, heat for 5 min. 
To set a timer, press the following buttons in order:  
[SET], "Timer (h:m)" [4], [5], [ENT]. 




6. Carefully remove from the hotplate with wafer tweezers and 









Procedure 2. Spin-coating  
Spin-coating is a step to apply photoresist onto the wafer. This 
section will outline the steps of spin coating SU-8, a common type of 
negative photoresist that is used in the MicroFabrication Laboratory. 
The procedure is similar for AZ1512, a positive photoresist, except it 
is deposited via syringe rather than pouring due to its lower viscosity. 
 
This step uses the Laurell spin-coater in the fume hood which can be 
seen in Figure 3. 




Preparation stage:  1. Turn on the spin coater using the left power strip 
switch under the fume hood (Figure 4).  If the display does not light up, turn on the unit power 







Figure 4: Spin-coater Power Strip 
 
Figure 5: Dataplate Hot Plates  
2. Turn on the two 7" Dataplate hotplates (Figure 5) using the 
right power strip switch under the fume hood (Figure 6), and set 
the left one to 65 °C and the right one to 95 °C as in Proc 1, 
Step 2 above. (Note, the "5" button sticks on one hotplate so 
use 96 °C if necessary). 
 
If foil is absent, damaged, or dirty, replace with new foil. 
 
 
Figure 6: Hot Plate Power Strip 
 
3. Press [Select Process] and choose the appropriate spin program according to your desired 
parameters. If none exist yet, you must enter a new spin program. Refer to the User Manual or 
Appendix 1 for programming. If you make any changers or additions, note your changes in 
the MFL logbook. 
 
Edit Program 10    
Step:001/002 Vac↓req Step:002/002 Vac↓req 
Time:00:10.0 Cpm:00 Time:00:30.0 Cpm:00 
Rpm : +00500 Loop:000 Rpm : +01600 Loop:000 
Acel: 0100 Goto:001 Acel: 0300 Goto:001 
Valv:   Valv:   
Sens:   Sens:   
 
The first step is a slow ramp to 500 rpm at 100 rpm/s and is designed to slowly 
spread the resist across the wafer. The second step spins faster to determine the 
final resist film thickness. Only the spin speed (in rpm) needs to be changed for 
different resist thicknesses; all other parameters should remain unchanged. 
 
4. Remove the spin-coater lid and verify the presence of a foil liner. If the foil is not present, line 
the bowl with foil to catch photoresist that is removed from the wafer during spinning. Ensure 
that the bowl periphery is covered above the height of the chuck and wafer, and also completely 
covering the bottom to the chuck. Rotate the chuck and ensure that the foil does not touch the 
chuck or impede rotation. 
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5. Select [Run Mode].  
 
6. Turn on the N2 supply, seen in Figure 7, by opening the 
main tank valve (marked in red). Ensure an output pressure of 
60-70 psi. If the display reads "Need CDA," open the round 
valve attached to the pressure regulator (outlined in green). 
Open the vacuum valve by aligning the black handle with the 





Figure 7: N2 Supply Tank Valves 
 
 
7. Make sure that the wafer is clean and dry. Visible dust on the 
wafer can be removed by gently blowing the wafer using the 
nitrogen gun (Figure 8), which is located on the right side of 




Figure 8: N2 Gun 
 
 
8. Position the 4" wafer alignment tool against the chuck, and 
using wafer tweezers or your gloved hand, touching only the 
edge, place the wafer on the chuck aligning to the marks on the 
alignment tool (Figure 9). 
 
 




9. Before removing the alignment tool, press the [Vacuum] button. A hiss should be audible, 
and the display should change from "Need vacuum" to "Ready". The wafer should now be held 
down on the chuck.  
 
10. Test your alignment by beginning the spin program. Press [START] and observe the edge of 
the wafer as it turns. It should wobble less than 5 mm. If not, press [STOP], then [Vacuum] to 
release the vacuum, realign, and return to step 8. Reset the spin program if necessary by pressing 
[Edit Mode] then [Run Mode] and ensuring the display reads "Ready".  
 
Coating Stage: 
1. Ensure the wafer is centered and the spin-coater is programmed and ready to spin.  
 
2. For SU8 2035 photoresists and similar high-viscosity materials, pour the resist directly from a   
50 mL conical tube. It will flow very slowly. Pour approximately 8-10 mL of resist onto the 




close enough to prevent thin filaments of resist from forming: about 1 cm. Once the resist blob 
covers about 5cm diameter, quickly move the tube toward the edge while tilting the tube 






















3. Press the [START] button of the spinner to start spin coating. The spin coating process takes 
about 1 minute, depending on the program. [OPTIONAL:] Near the end of the second spin step, 
use a piece of Al foil, rolled into a rod to collect resist streams that fly off of the wafer. Do not 
touch the edge, but bring the rod close. This will clean up the resist at the edge and somewhat 
reduce the edge bead, or thicker later at the edge due that forms due to surface tension.  
 
4. The spinner will stop automatically when spin coating is completed.  
 
5. Verify that the photoresist has been uniformly coated. If striations and streaks are  
observed, the spin coating was not successful. Some causes may include: 
- dust particles on the surface (clean it better),   
- bubbles in the photoresist (heat the resist tube to 40-50 °C in a water bath to 
remove them; see resist datasheet for more information)   
- insufficient resist volume applied  
 
6. Press [Vacuum] to release the chuck vacuum.  
 
7. When the last wafer has been coated, close the vacuum and CDA valves at the N2 tank.  
 
Procedure 3. Prebake (Soft Bake)  
The prebake (Soft Bake) procedure is required to densify the 
photoresist following spin coating and evaporate the solvent. 
In order to reduce thermal stresses due to the substantial 
difference in coefficient of thermal expansion between Si 
and resist, the temperature should be raised and lowered 
gradually in a 2-step process, first at 65 °C, then at 95 °C, 
then back to 65 °C. 
Figure 11: 65° Hotplate 
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This step uses the two 7" Dataplate hotplates in the fume hood. 
 
1. Use the "removal tool" to transfer the wafer from the spinner chuck to the 65 °C hotplate (See 
Figure 11). Set the timer for the desired time at this temperature, and cover the wafer with a foil 
tent (Figure 13). 
 
2. Transfer the wafer from the 65 °C hotplate to the 95 
°C hotplate (Figure 12). Set the timer for the desired 
time at this temperature and cover with a foil tent 
(Figure 13). Use wafer tweezers to lift up the edge, 
but don't grab the wafer edge, since the resist is still 






Figure 12: 95° Hotplate 
 
3. Return the wafer to the 65 °C hotplate for 3 minutes, covered, 
then transfer it to the clean hood to cool to room temperature. Be 
sure to place your hand underneath as you move the wafer from 
the fume hood to clean hood: if you drop it, it'll shatter. 
Figure 13: Foil Tent 
 
Procedure 4. UV exposure  
The UV exposure procedure exposes the photoresist layer to collimated 365 nm UV light via 
an LED source through a photomask. A negative resist becomes crosslinked and insoluble in 
developer when exposed, whereas a positive photoresist becomes soluble in developer when 
exposed. This procedure assumes that a transparency photomask will be used in direct contact 
with the resist layer. 
 
This step uses the UV-KUB exposure system in the clean hood (Figure 14). 
 
Preparation stage: (this can be done during the prebake 
procedure 3)  
1. Turn on the UV-KUB via the power switch at the back 
left, just above the power cord. Press the silver power 
button on the front panel, lower right. The touchscreen 
should light up and display "UV-KUB"  
 
2. Touch the screen to reach the main menu. Touch [Settings] 
and [Drawer] to unlock the drawer. Wave your hand near the 
door sensor at the lower left to open the drawer. If there is a 
wafer or mask present, remove them. Place the 4"x 5" glass   
slide on the tray and wave near the door sensor to close it. Figure 14: UV KUB 
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 3. Return to the [Settings] menu (touch the [X] in the upper right of the screen). Touch 
[Illumination] to calibrate the UV intensity. It should display about 23.4 mW/cm2 through the 










Figure 15: UV Intensity Calibration 
 



















5. Program the desired exposure duration and intensity. Enter 
the time using the touchscreen numbers, then a unit ([h], [m], 
[s] for hours, minutes, seconds), then [v] to confirm. Note that 
decimal values are not permitted, so round to the nearest 
second. Next enter the intensity in %, usually 100%, and [v] to 
confirm (Figure 17). 
 
 
Figure 17: Duration and Intensity 
 
 
6. Test the exposure by touching [Insolate]. The drawer will open (Figure 18). Wave it closed. 
The display should read 
"Loading in Progress". 
Touch the screen to start the 
exposure. Verify that the 
countdown timer begins at 




Figure 18: Insolate 
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 7. The exposure will end automatically and alert with a loud beep (silence by touching the 
screen). The drawer will open automatically. Remove the glass slide if present. 
 
Mask alignment stage:  1. Transfer the room temperature, resist-coated wafer to the 
UV-KUB tray, centering it in the circular pattern (Figure 19).  
 
2. Observe the position of any defects in the resist layer. You will 
try to rotate your photomask such that these defects are removed 
during development; i.e. they are covered with black mask regions if 
a negative resist, or are covered with clear mask region if a positive 
resist.   
Figure 19: Loaded Wafer 
3. Cut out the photomask circle  using scissors, taking care not to kink the transparency 
film. Ensure it is free of dust, and gently wipe with a lint-
free cleanroom wipe or blow with the N2 gun if necessary. 
 
4. Place the photomask over the resist-coated wafer and orient 
it such that any defects will be removed during development 
(Figure 20). 
 
Figure 20: Photomask placed on 




5. Place the 4" x 5" glass slide over the wafer and mask to keep it flat and in direct contact. First 
tilt the 5" side to the back corner supports, then gently move it toward you so it rests on the 
bottom tray surface. Finally, gently lower the glass plate onto the wafer, ensuring it is fully 















Figure 21: Slowly lower glass on top of photomask and wafer combination 
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Exposure stage:  
1. When you are satisfied with the 
mask orientation and glass plate 
placement, wave the door closed 
(Figure 22). Touch the screen. 
 
2. When is asks: "What do you want to 
do?", touch [Continue] on the screen. 
The last used program will begin  
automatically after 1-2s. Verify the correct exposure. If anything is awry, immediately press the 
large red button to abort and retry. 
 
3. The exposure will end automatically and alert with a loud beep (silence by touching the 
screen). The drawer opens automatically.  
 
4. Gently lift the glass slide with wafer tweezers and set aside. Gently lift the photomask 

























5. Observe the resist surface. At this point, no pattern should be easily visible. If it is, the 
exposure time was too long.  
 
6. Wave the drawer closed when done exposing, then touch the screen and select [Cancel].  
 
Procedure 5. Post-Exposure Bake (PEB)  
The post-exposure bake completes the process of crosslinking a negative resist or solubilizing a 
positive resist. As in the prebake, a two-step heating and cooling is required to minimize resist 
layer thermal stresses. 
 
This step uses the two 7" Dataplate hotplates in the fume hood. 
 




1. Transfer the wafer from the UV-KUB to the 65 °C hotplate in the fume hood. Be sure to place 
your hand underneath as you move the wafer so it doesn't drop. Set the timer for the desired time 
at this PEB temperature.  
 
2. Observe the resist surface.  With ideal exposure,   the mask pattern will become slightly visible in 5-30 
s (See Figure 24). Cover with a foil tent. 
 
3. Transfer the wafer from the 65 °C hotplate to 
the 95 °C hotplate and cover. Set the timer for the 
desired time at this temperature. 
 
4. Return the wafer to the 65 °C hotplate for 3 
minutes, then transfer it to a cleanroom wipe on the  
work surface to cool to room temperature. At this                               Figure 24: Slightly Visible 
mask pattern point, the mask pattern should be clearly visible. If  





Procedure 6. Development  
The development step dissolves away the unexposed negative photoresist (or exposed positive 
photoresist). It is performed by immersing the wafer in developer liquid and agitating until the 
resist is dissolved and only the insoluble pattern remains. 
 
This procedure uses a glass dish and developer chemical in the fume hood. Developers are 
located in the flammable cabinet below the fume hood, left side. 
 
1. Ensure the glass dish is clean. Clean and dry with a cleanroom wipe if necessary. Pour 
developer in the dish to about 0.5-1 cm depth.  
 
2. Immerse the wafer in developer and gently slosh/agitate, taking care not to splash developer 





















3. Observe the wafer periodically. Bare Si regions 
will become visible after ~30s - 1 min. The resist at 
the edge is thicker than in the center, and therefore 
tends to be the last part to dissolve away. See Figure   
26.  
 
4. When all resist appears dissolved, remove it from 
the developer bath with wafer tweezers and run under 
a gentle stream of water in the hood sink. Grasp the 
wafer in your hands at the edges to ensure it doesn't 
fall and break! See Figure 27.  
 

































Figure 26: Lighter parts of wafer show 
dissolved and bare Si regions (highlighted in 
red) and darker spots show where dissolving 
has not yet taken place (highlighted in green) 
 
5. After both front and back sides are rinsed in H2O, dry 
both sides with the N2 gun. Bring the nozzle close to the wafer and sweep side to side, especially in areas with small 
resist features (Figure 27).  
 
6. Inspect the wafer as described in Procedure 7 below, and 
then perform a final cleaning development by holding the 
wafer with tweezers horizontally over the dish and squirting   a small amount of fresh developer on the wafer (Figure 28). 
Gently slosh side-to-side for about 15s. Rinse with H2O 
and dry with a N2 gun.   Figure 28: Slosh developer side to side on 
wafer for final cleaning 
 
 
Procedure 7. Inspection  
Inspection is a step to verify general process quality and the development process. This 
section will outline the main feature distortions that are encountered in photolithography 
process. The Zeiss Stemi-2000 stereo microscope is equipped with a fiber-optic light ring and 




After initial development and rinsing, the wafer will appear 
dirty (see Figure 29). This is OK! It is due to the resist that 
has dissolved in the developer and will be cleaned to a shiny 
surface after brief wash with fresh developer. Also, sharp 
corners and large resist fields will likely display surface 
cracks. This is also OK! It is due to the thermal stresses 
during bakes, which were minimized by gradual heating and 
cooling but not fully eliminated. These cracks will be  
eliminated with the Post-bake, Procedure 8. 
Figure 29: Dirty Wafer 
 
 
1. Development time. Pay attention to the smallest features in the resist pattern. Lines should be 
sharp, with no evidence of resist material in regions where it should be removed. If not,  
development is incomplete. Return the wafer to the developer 
bath and repeat for ~30s, then rinse, dry, and reinspect. 
Instead, if the resist layer that should remain looks especially 
cloudy or rough, the wafer may be over-developed. 
Additionally, overdevelopment may narrow a resist feature or 
widen a resist "hole", and underdevelopment may do the 
opposite as in Figure 30. 
 
Figure 30: Under-development  
and Over-development. 
 
2. Bake times and temperatures. The extent to which a feature deviates from its ideal size is a 
function of the exposure time, prebake temperature, prebake time, development temperature 
and development time. Any of these parameters could be the cause for overdevelopment or 
underdevelopment and it is therefore important that one understand some important 
troubleshooting techniques. The key idea troubleshoot the distorted feature is to observe the 
effect of changing a parameter while holding the other parameters at constant. The following 
example illustrates this idea. 
 
Figure 31 shows the changes in feature size as the exposure time is increased, while holding the 
other parameters at constant. It can be  
observed that by changing the exposure time 
while holding the other parameters at constant, 
there is a time window where the feature size 
is optimal, i.e. between 15s and 25s in this 
example. If the changing of this parameter 
does not produce the desired feature size, the 
problems are most likely to be caused by other 
parameters or combinations of several  parameters. Repeated troubleshooting with 
other parameters should  
be carried out. 
 Figure 31:Changes in feature size due to increasing exposure time 
Procedure 8. Post-bake  
The Postbake procedure is required to stabilize and harden the developed photoresist prior to 
processing steps that the resist will mask. Typical post-bake temperature is 150 °C for 30 min for 
SU8 (or 90-120°C for 5 min for other thin resists). 
 
This procedure uses any of the Dataplate hotplates. 
 
1. Place the developed wafer on a hotplate at no more than 65 °C.   
2. Set the ramp rate to 6 °C/min or 360 °C/hr: [SET], "Ramp °C /hr" [6], [3], [6], [0], [ENT]. 
Set temperature to 150°C. Set the timer for 45 minutes. Set the hotplate to automatically turn 
off then the timer ends, by pressing "Auto Off" [8]. Cover with a foil tent.   
3. The hotplate will slowly ramp up to 150°C over about 15 mins, maintain temperature for 
~30mins, then turn off and slowly return to room temperature. This will take around 1 hr total.   4. After the wafer has returned to room temperature, inspect the wafer again and verify that 
surface cracks have disappeared. Document selected microscope fields with a camera.  
 
Post-procedure Cleanup  Following a photolithography process, equipment must be cleaned and properly shut down. 
Perform the following steps: 
 
1. Ensure you have logged your usage information in the MFL logbook. This is important, as 
the MFL is a shared use facility. Note any consumables running low, dirty areas, and any other 
relevant information.   
2. Clean hood. Turn off the hotplate and UV-KUB via the front panel (silver button, lower right) 
and back switch (rear, lower left, above the power cord). Then power off the lights and blower of 
the clean hood itself.   
3. Microscope. Turn off the illumination system.   
4. Fume hood. Dispose of photoresist devleoper into the properly-labeled waste container, stored 
below the fume hood on the right side. Place the waste container in the hood sink, and use a 
funnel while pouring from the glass dish. Wipe the dish with a cleanroom wipe. Then rinse it 
with water in the large sink and set to dry.   
5. Power off the spin coater and hotplates if not in use.  
6. Close the main N2 tank valve and depressurize with the gun.  7. Clean up the benches, put away your photomasks, etc.   8. Dispose of any photoresist-contaminated solid (foil, gloves, etc) in the waste container labeld 
PHOTORESIST WASTE.  
	  


















Appendix	  C:	  SOP	  for	  BrdU	  Assay	  
Hydrogel	  Barrier	  Formation	  in	  a	  Migration	  Device	  
Standard	  Operating	  Procedure	  
Team	  42	  MQP	  
Materials:	  
BrdU	  Stock	  Solution	  (refrigerated)	  
DPBS	  +	  Calcium	  
DPBS	  	  
Ice	  Cold	  Methanol	  








Appendix	  D:	  SOP	  For	  Plasma	  Bonding	  Devices	  
Plasma	  Bonding	  Microfluidic	  Devices	  
Standard	  Operating	  Procedure	  








3	  inch	  X	  1	  inch	  Glass	  Slide	  
KimWipe	  
Procedure:	  
1 Use	  a	  razor	  blade	  to	  cut	  out	  individual	  devices	  from	  the	  larger	  PDMS	  mold.	  
2 Punch	  inlet	  and	  outlet	  holes	  in	  the	  devices	  using	  the	  1mm	  hole	  punch.	  Clean	  the	  holes	  by	  
blasting	  with	  water,	  ethanol,	  then	  water	  again.	  
3 Clean	  the	  surface	  of	  the	  PDMS	  device	  to	  be	  bonded,	  as	  well	  as	  the	  glass	  slide,	  using	  water,	  then	  
ethanol	  then	  water	  again.	  
4 Dry	  the	  PDMS	  device	  and	  the	  glass	  slide	  using	  a	  KimWipe.	  
5 Remove	  any	  remaining	  dust	  using	  scotch	  tape.	  
6 Place	  the	  PDMS	  device	  and	  glass	  slide	  in	  the	  plasma	  bonder,	  with	  the	  side	  to	  be	  bonded	  facing	  
up.	  
7 Close	  the	  door	  and	  hold	  it	  in	  place	  while	  the	  vacuum	  is	  turned	  on.	  Hold	  the	  door	  steady	  for	  at	  
least	  5	  seconds.	  
8 Allow	  the	  vacuum	  pump	  to	  remove	  air	  form	  the	  chamber	  for	  at	  least	  10	  seconds	  before	  turning	  
on	  the	  plasma.	  
9 Turn	  on	  the	  plasma	  bonder,	  and	  wait	  until	  a	  dark	  purple	  glow	  is	  emitted.	  Open	  the	  needle	  valve	  
slightly	  until	  the	  glow	  becomes	  bright	  orange	  in	  the	  center.	  
10 Expose	  the	  device	  and	  slide	  to	  the	  plasma	  for	  1	  minute.	  	  
11 After	  1	  minute,	  turn	  of	  the	  plasma	  bonder,	  then	  the	  vacuum,	  then	  release	  the	  vacuum	  using	  the	  
ball	  valve.	  
12 Remove	  the	  door	  and	  carefully	  remove	  the	  PDMS	  device	  and	  glass	  slide,	  without	  touching	  the	  
surfaces	  to	  be	  bonded.	  
13 Invert	  the	  glass	  slide	  onto	  the	  PDMS	  device	  and	  apply	  slight	  pressure	  for	  15	  seconds.	  Try	  to	  pry	  
up	  the	  PDMS	  device	  at	  the	  corners	  to	  ensure	  it	  was	  properly	  bonded.	  




Appendix	  E:	  SOP	  for	  Hydrogel	  Barrier	  Formation	  
Hydrogel	  Barrier	  Formation	  in	  a	  Migration	  Device	  
Standard	  Operating	  Procedure	  
Team	  42	  MQP	  
Materials:	  
	  
6	  blocking	  pins	  
1mL	  PureCol	  collagen	  (frozen)	  
1	  Syringe	  without	  plunger	  (3mL)	  
1	  Syringe	  with	  plunger	  (1mL)	  
1	  3-­‐way	  valve	  
1ft	  Tygon	  tubing	  with	  metal	  inlet	  pin	  
1	  migration	  device	  
	  
Procedure:	  
1. Incubate	  the	  migration	  device	  to	  be	  used	  in	  a	  650	  C	  oven	  overnight	  to	  restore	  its	  hydrophilic	  
properties.	  
2. Attach	  both	  syringes	  and	  the	  Tygon	  tubing	  to	  the	  3-­‐way	  valve.	  
3. Insert	  blocking	  pins	  into	  each	  of	  the	  holes	  on	  the	  migration	  device	  except	  the	  hydrogel	  inlet	  and	  
outlet.	  
4. Load	  1mL	  PureCol	  collagen	  into	  the	  3mL	  syringe	  
5. Prime	  the	  syringes	  to	  remove	  bubbles	  by	  repeatedly	  drawing	  collagen	  into	  the	  1mL	  syringe	  and	  
then	  expelling	  it	  using	  the	  plunger	  until	  no	  bubbles	  are	  observed	  in	  either	  syringe	  or	  the	  valve	  
itself.	  
6. Prime	  the	  tubing	  by	  allowing	  the	  collgen	  to	  flow	  through	  it	  until	  a	  drop	  is	  observed	  at	  the	  end	  of	  
the	  tubing,	  then	  stop	  the	  flow	  by	  turning	  the	  valve	  control	  knob.	  
7. Insert	  the	  inlet	  tube	  into	  the	  inlet	  hole	  in	  the	  migration	  device	  and	  place	  under	  a	  microscope	  to	  
observe	  the	  flow.	  
8. Open	  the	  valve	  to	  allow	  the	  collagen	  to	  flow	  through	  the	  tubing	  and	  into	  the	  device.	  
9. Raise	  the	  syringe	  setup	  above	  the	  level	  of	  the	  device	  until	  the	  collagen	  has	  almost	  reached	  the	  
barrier	  channel,	  then	  lower	  the	  syringe	  until	  a	  very	  slow	  flowrate	  is	  observed.	  
10. Allow	  the	  collagen	  to	  slowly	  flow	  through	  the	  channel,	  contacting	  each	  pair	  of	  posts	  as	  it	  travels.	  	  	  
11. Once	  the	  collagen	  has	  flowed	  about	  500um	  into	  the	  hydrogel	  outlet	  channel,	  stop	  the	  flow	  by	  
lowering	  the	  syringe	  to	  the	  same	  level	  as	  the	  device.	  
12. Cut	  the	  inlet	  tube	  close	  to	  the	  device	  with	  scissors	  using	  a	  smooth	  motion	  and	  minimally	  
compressing	  the	  tube	  during	  the	  cut.	  
13. Transfer	  the	  device	  to	  a	  370	  C	  incubator	  for	  90	  minutes.	  	  	  
14. Carefully	  remove	  the	  blocking	  pins	  from	  the	  other	  channel	  inlets	  and	  outlets.	  The	  device	  can	  







Appendix	  F:	  BME	  Educational	  Objectives	  
An	  ability	  to	  design	  a	  system,	  component,	  or	  process	  to	  meet	  desired	  needs	  within	  realistic	  
constraints	  such	  as	  economic,	  environmental,	  social,	  political,	  ethical,	  health	  and	  safety,	  
manufacturability,	  and	  sustainability	  (ABET	  3c)	  while	  incorporating	  appropriate	  engineering	  
standards	  (ABET	  Criterion	  5)	  	  
I. multiple	  realistic	  constraints	  (economic,	  environmental,	  social,	  political,	  ethical,	  health	  
and	  safety,	  manufacturability)	  –	  page(s)	  57-­‐58	  
II. appropriate	  engineering	  standards	  -­‐	  	  page(s)	  36-­‐38	  
	  	  
4.	  An	  ability	  to	  function	  on	  multidisciplinary	  teams	  (3d).	  	  page(s)	  N/A	  
	  	  
6.	  	  	  An	  understanding	  of	  professional	  and	  ethical	  responsibilities	  (3f)	  
I. Professional	  –	  page(s)	  49-­‐52	  
II. Ethical	  –	  page(s)	  58	  
	  	  
7.	  	  	  An	  ability	  to	  communicate	  effectively	  (3g).	  pages	  54-­‐59	  
	  	  
8.	  	  The	  broad	  education	  necessary	  to	  understand	  the	  impact	  of	  engineering	  solutions	  in	  a	  
global,	  economic,	  environmental,	  and	  societal	  context	  (3h).	  	  
I. Economic	  –	  page(s)	  59	  
II. Environmental	  –	  page(s)	  57	  
	  	  
10.	  A	  knowledge	  of	  contemporary	  issues	  (3j).	  	  page(s)	  10-­‐13,	  73-­‐75	  	  
	  
